An interventional study of Blood sampling and Assessment of body temperature in Malaria and Malaria Vaccines, sponsored by GlaxoSmithKline. Completed at 8 sites in 6 countries. Open to participants aged 6 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-18.
Sponsored by GlaxoSmithKline · Not applicable, Interventional, and Other
The aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (NCT00866619).
This study is a multicenter epidemiology study at centers that are participating in GSK's pivotal Phase III candidate malaria vaccine 110021 ( NCT00866619) trial and will involve 4 annual cross sectional surveys performed preferably at peak transmission.
There will be no study vaccine administered in this epidemiology study.
1,184 studies on the registry are indexed under Malaria; 79 are open to participants now.
This study's enrollment of 21,618 is above the median of 252 across 937 interventional studies indexed under Malaria.
Browse Malaria studies →GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 118 are open to participants now.
Of its 264 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects at least 6 months of age at the time of Survey 1, conducted at Year 1 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study.
Procedure: Blood sampling · Procedure: Assessment of body temperature
Subjects at least 6 months of age at the time of Survey 2, conducted at Year 2 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study.
Procedure: Blood sampling · Procedure: Assessment of body temperature
Subjects at least 6 months of age at the time of Survey 3, conducted at Year 3 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study.
Procedure: Blood sampling · Procedure: Assessment of body temperature
Subjects at least 6 months of age at the time of Survey 4, conducted at Year 4 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study.
Procedure: Blood sampling · Procedure: Assessment of body temperature
Capillary blood samples collected by finger/heel prick
Assessment of axial body temperature with a digital thermometer
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), for Each Survey
The Overall parasite prevalence (PP) data were collected across centers from subjects aged between and including: 6 months to 4 Years (6M-4Y), 5 to 19 Years (5-19 Y) and 20 Years or older (20Y+), for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated.
Time frame: At each Survey visit
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), According to Annual Age for Children of 4 Years or Less, for Each Survey
The overall parasite prevalence (PP) data were collected across centers from subjects aged 4 years or less, for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated.
Time frame: At each Survey visit
Number of Subjects With Anemia and Severe Anemia for Each Survey
The overall anemia and severe anemia data were collected across centers from subjects, aged between and including: 6M-4Y, 5-19 Y and 20Y+, for each survey. Hemoglobin (Hgb) cut-offs used to define anemia and severe anemia in people living at sea level are: Anemia: children 6M to 5Y, Hgb lower than (\<) 11 gram per deciliter (g/dL); children 5-11Y, Hgb \<11.5 g/dL; children 12-13Y, Hgb \<12 g/dL; non-pregnant females, Hgb \<12 g/dL; pregnant females, Hgb \<11 g/dL; males, Hgb \<13 g/dL. Severe anemia: any age or gender, Hgb \<7 g/dL. Missing/ Not applicable (NA) = if age or pregnancy status was not available. Among each age category, results for both sub-categories "Yes" (subjects with anemia) and "Missing/NA" are presented below, results for the category "No" can be deduced from the number of participants analyzed in the corresponding age category, minus (number of "Yes" + number of "Missing/NA"). Similar presentation is followed for "severe anemia" results.
Time frame: During the survey period (approximatively 1 year)
Number of Subjects With Anti-malarial Therapy in Survey 1, According to Parasite Density
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
Time frame: During the survey period (approximatively 1 year)
Number of Subjects With Anti-malarial Therapy in Survey 2, According to Parasite Density
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
Time frame: During the survey period (approximatively 1 year)
Number of Subjects With Anti-malarial Therapy in Survey 3, According to Parasite Density
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
Time frame: During the survey period (approximatively 1 year)
Number of Subjects With Anti-malarial Therapy in Survey 4, According to Parasite Density
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
Time frame: During the survey period (approximatively 1 year)
Mean Number of Days With Malaria Treatment at Survey 1
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the 14 day-period before the malaria treatment
Mean Number of Days With Malaria Treatment at Survey 2
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the 14 day-period before the malaria treatment
Mean Number of Days With Malaria Treatment at Survey 3
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the 14 day-period before the malaria treatment
Mean Number of Days With Malaria Treatment at Survey 4
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the 14 day-period before the malaria treatment
Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 1
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: In the last 24 hours or at the survey visit
Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 2
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: In the last 24 hours or at the survey visit
Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 3
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: In the last 24 hours or at the survey visit
Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 4
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: In the last 24 hours or at the survey visit
Mean Number of Days With Fever at Survey 1
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the survey period (approximatively 1 year)
Mean Number of Days With Fever at Survey 2
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the survey period (approximatively 1 year)
Mean Number of Days With Fever at Survey 3
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the survey period (approximatively 1 year)
Mean Number of Days With Fever at Survey 4
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: During the survey period (approximatively 1 year)
Axillary Temperature at Visit in Survey 1
The mean and standard deviation of the axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Axillary Temperature at Visit in Survey 2
The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Axillary Temperature at Visit in Survey 3
The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Axillary Temperature at Visit in Survey 4
The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Living in the Same House at Survey 1
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Living in the Same House at Survey 2
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Living in the Same House at Survey 3
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Living in the Same House at Survey 4
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Mean Number of Subjects Living in the Same House at Survey 1
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Mean Number of Subjects Living in the Same House at Survey 2
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Mean Number of Subjects Living in the Same House at Survey 3
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Mean Number of Subjects Living in the Same House at Survey 4
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by Localisation and Type of Location at Survey 1
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural or missing) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants or missing type of location). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by Localisation and Type of Location at Survey 2
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by Localisation and Type of Location at Survey 3
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by Localisation and Type of Location at Survey 4
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 1
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other and missing. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet, missing. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 2
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 3
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 4
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 1
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other, missing. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open, missing. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 2
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 3
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 4
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 1
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water), missing; and Presence of electricity (PE): Yes, No, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 2
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 3
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 4
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
Time frame: At Survey visit
Number of Subjects With Malaria Prevention Measures (MPM) at Each Survey
The malaria prevention measures (MPM) data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for each Survey. The MPM results include the following categories: Use of Mosquito coils over 7 days (UMc \> 7D), Use of Insecticide spray over 7 days (UIs \> 7D), Use of Commercial Repellents over 7 days (UCR \> 7D), Use of Traditional Repellents over 7 days (UTR \> 7D), Use of none of above over 7 days (Una \>7D), Use of indoor residual spray in past 12 months to spray interior walls (Uirs past 12M), Use of indoor residual spray - number of months ago (Uirs-nM) or Use of indoor residual spray- no spray (Uirs-no spray): the number of months ago for each Uirs-nM sub-categories is defined using the following \[x Months\]. Not all Uirs-nM sub-categories were analyzed in each survey.
Time frame: At each Survey visit
Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 1
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
Time frame: At Survey visit
Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 2
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
Time frame: At Survey visit
Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 3
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
Time frame: At Survey visit
Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 4
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
Time frame: At Survey visit
Number of Subjects With Serious Adverse Events (SAEs) Related to Study Procedure for Each Survey
Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity. Capillary blood sampling was the only invasive procedure involved in this study. SAEs related to this procedure were recorded at the Survey visit.
Time frame: At each Survey visit
For each year and each site, approximately 400 subjects at least 6 months and \< 5 years old, approximately 200 subjects at least 5 years and \< 20 years old and approximately 200 subjects at least 20 years old were to be enrolled. The study was conducted at 8 sites and 6 countries for the first 3 surveys and 3 sites from 3 countries for Survey 4.
| Milestone | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) |
|---|---|---|---|---|
| Started | 6404 | 6414 | 6400 | 2400 |
| Completed | 6404 | 6414 | 6400 | 2400 |
| Not completed | 0 | 0 | 0 | 0 |
The Overall parasite prevalence (PP) data were collected across centers from subjects aged between and including: 6 months to 4 Years (6M-4Y), 5 to 19 Years (5-19 Y) and 20 Years or older (20Y+), for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated.
| Participants | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) |
|---|---|---|---|---|
| 6M-4Y, Overall | 720 | 574 | 605 | 345 |
| 5-19Y, Overall | 446 | 469 | 483 | 278 |
| 20+Y, Overall | 147 | 146 | 193 | 92 |
The overall parasite prevalence (PP) data were collected across centers from subjects aged 4 years or less, for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated.
| Participants | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) |
|---|---|---|---|---|
| Children aged 0 year | 21 | 38 | 41 | 25 |
| Children aged 1 year | 94 | 75 | 128 | 62 |
| Children aged 2 years | 139 | 122 | 125 | 86 |
| Children aged 3 years | 223 | 174 | 135 | 86 |
| Children aged 4 years | 243 | 165 | 176 | 86 |
The overall anemia and severe anemia data were collected across centers from subjects, aged between and including: 6M-4Y, 5-19 Y and 20Y+, for each survey. Hemoglobin (Hgb) cut-offs used to define anemia and severe anemia in people living at sea level are: Anemia: children 6M to 5Y, Hgb lower than (\<) 11 gram per deciliter (g/dL); children 5-11Y, Hgb \<11.5 g/dL; children 12-13Y, Hgb \<12 g/dL; non-pregnant females, Hgb \<12 g/dL; pregnant females, Hgb \<11 g/dL; males, Hgb \<13 g/dL. Severe anemia: any age or gender, Hgb \<7 g/dL. Missing/ Not applicable (NA) = if age or pregnancy status was not available. Among each age category, results for both sub-categories "Yes" (subjects with anemia) and "Missing/NA" are presented below, results for the category "No" can be deduced from the number of participants analyzed in the corresponding age category, minus (number of "Yes" + number of "Missing/NA"). Similar presentation is followed for "severe anemia" results.
| Participants | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) |
|---|---|---|---|---|
| Overall Yes, Anaemia, 6M-4Y | 1974 | 2025 | 1974 | 871 |
| Missing/NA Anemia, 6M-4Y | 4 | 2 | — | — |
| Overall Yes, Anemia, 5-19Y | 806 | 794 | 765 | 371 |
| Missing/NA Anemia, 5-19Y | 2 | 2 | — | — |
| Overall Yes, Anemia, 20Y+ | 673 | 631 | 651 | 313 |
| Missing/NA Anemia, 20Y+ | 1 | 0 | — | — |
| Overall Yes, Severe anaemia, 6M-4Y | 85 | 70 | 84 | 34 |
| Missing/NA Severe anemia, 6M-4Y | 1226 | 1172 | 1219 | 322 |
| Overall Yes, Severe anaemia, 5-19Y | 10 | 12 | 19 | 5 |
| Missing/NA Severe anemia, 5-19Y | 807 | 833 | 847 | 235 |
| Overall Yes, Severe anaemia, 20Y+ | 17 | 14 | 9 | 4 |
| Missing/NA Severe anemia, 20Y+ | 915 | 956 | 944 | 287 |
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, MT in past 14 days, Yes | 22 | 9 | 2 | 12 | 262 |
| 6M-4Y, MT in past 14 days, No | 351 | 161 | 56 | 107 | 2218 |
| 6M-4Y, EDMT *, Ongoing | 3 | 2 | 0 | 0 | 28 |
| 6M-4Y, EDMT *, 1-3 days | 18 | 5 | 2 | 9 | 206 |
| 6M-4Y, EDMT *, ≥ 4days | 1 | 2 | 0 | 3 | 27 |
| 6M-4Y, EDMT *, Missing/Not applicable | 351 | 161 | 56 | 107 | 2219 |
| 6M-4Y, OM in past 14 days, Yes | 35 | 33 | 21 | 33 | 445 |
| 6M-4Y, OM in past 14 days, No | 338 | 137 | 37 | 86 | 2035 |
| 6M-4Y, DOM *, Ongoing | 8 | 7 | 2 | 5 | 79 |
| 6M-4Y, DOM *, 1-7 days | 25 | 26 | 19 | 27 | 365 |
| 6M-4Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 1 |
| 6M-4Y, DOM *, Missing/Not applicable | 340 | 137 | 37 | 87 | 2035 |
| 6M-4Y, MH in the last 3 months, Yes | 7 | 4 | 1 | 7 | 90 |
| 6M-4Y, MH in the last 3 months, No | 366 | 166 | 57 | 112 | 2390 |
| 5-19Y, MT in past 14 days, Yes | 5 | 6 | 4 | 2 | 85 |
| 5-19Y, MT in past 14 days, No | 289 | 65 | 19 | 56 | 1082 |
| 5-19Y, EDMT *, Ongoing | 1 | 0 | 0 | 0 | 5 |
| 5-19Y, EDMT *, 1-3 days | 4 | 6 | 4 | 1 | 75 |
| 5-19Y, EDMT *, ≥ 4days | 0 | 0 | 0 | 1 | 5 |
| 5-19Y, EDMT *, Missing/Not applicable | 289 | 65 | 19 | 56 | 1082 |
| 5-19Y, OM in past 14 days, Yes | 29 | 12 | 8 | 7 | 143 |
| 5-19Y, OM in past 14 days, No | 265 | 59 | 15 | 51 | 1024 |
| 5-19Y, DOM *, Ongoing | 4 | 1 | 1 | 2 | 17 |
| 5-19Y, DOM *, 1-7 days | 25 | 11 | 7 | 5 | 125 |
| 5-19Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, DOM *, Missing/Not applicable | 265 | 59 | 15 | 51 | 1025 |
| 5-19Y, MH in the last 3 months, Yes | 0 | 3 | 0 | 1 | 24 |
| 5-19Y, MH in the last 3 months, No | 294 | 68 | 23 | 57 | 1143 |
| 20Y+, MT in past 14 days, Yes | 1 | 0 | — | 0 | 102 |
| 20Y+, MT in past 14 days, No | 118 | 17 | — | 11 | 1339 |
| 20Y+, EDMT *, Ongoing | 0 | 0 | — | 0 | 14 |
| 20Y+, EDMT *, 1-3 days | 1 | 0 | — | 0 | 80 |
| 20Y+, EDMT *, ≥ 4days | 0 | 0 | — | 0 | 8 |
| 20Y+, EDMT *, Missing/Not applicable | 118 | 17 | — | 11 | 1339 |
| 20Y+, OM in past 14 days, Yes | 20 | 6 | — | 2 | 203 |
| 20Y+, OM in past 14 days, No | 99 | 11 | — | 9 | 1238 |
| 20Y+, DOM *, Ongoing | 5 | 1 | — | 1 | 41 |
| 20Y+, DOM *, 1-7 days | 15 | 5 | — | 1 | 158 |
| 20Y+, DOM *, ≥ 8 days | 0 | 0 | — | 0 | 2 |
| 20Y+, DOM *, Missing/Not applicable | 99 | 11 | — | 9 | 1240 |
| 20Y+, MH in the last 3 months, Yes | 0 | 2 | — | 0 | 18 |
| 20Y+, MH in the last 3 months, No | 119 | 15 | — | 11 | 1423 |
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, MT in past 14 days, Yes | 14 | 6 | 2 | 5 | 257 |
| 6M-4Y, MT in past 14 days, No | 269 | 142 | 65 | 71 | 2366 |
| 6M-4Y, EDMT *, Ongoing | 1 | 3 | 0 | 1 | 25 |
| 6M-4Y, EDMT *, 1-3 days | 12 | 1 | 1 | 4 | 206 |
| 6M-4Y, EDMT *, ≥ 4days | 1 | 2 | 1 | 0 | 26 |
| 6M-4Y, EDMT *, Missing/NA | 269 | 142 | 65 | 71 | 2366 |
| 6M-4Y, OM in past 14 days, Yes | 42 | 15 | 9 | 17 | 535 |
| 6M-4Y, OM in past 14 days, No | 241 | 133 | 58 | 59 | 2088 |
| 6M-4Y, DOM *, Ongoing | 12 | 6 | 3 | 2 | 118 |
| 6M-4Y, DOM *, 1-7 days | 30 | 9 | 6 | 15 | 410 |
| 6M-4Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 7 |
| 6M-4Y, DOM *, Missing/NA | 241 | 133 | 58 | 59 | 2088 |
| 6M-4Y, MH in the last 3 months, Yes | 3 | 3 | 2 | 3 | 77 |
| 6M-4Y, MH in the last 3 months, No | 280 | 145 | 65 | 73 | 2546 |
| 5-19Y, MT in past 14 days, Yes | 11 | 3 | 2 | 4 | 77 |
| 5-19Y, MT in past 14 days, No | 322 | 68 | 27 | 32 | 1081 |
| 5-19Y, EDMT *, Ongoing | 1 | 1 | 0 | 0 | 11 |
| 5-19Y, EDMT *, 1-3 days | 8 | 1 | 2 | 4 | 66 |
| 5-19Y, EDMT *, ≥ 4days | 2 | 1 | 0 | 0 | 0 |
| 5-19Y, EDMT *, Missing/NA | 322 | 68 | 27 | 32 | 1081 |
| 5-19Y, OM in past 14 days, Yes | 33 | 10 | 8 | 9 | 134 |
| 5-19Y, OM in past 14 days, No | 300 | 61 | 21 | 27 | 1024 |
| 5-19Y, DOM *, Ongoing | 7 | 1 | 0 | 1 | 30 |
| 5-19Y, DOM *, 1-7 days | 26 | 9 | 8 | 8 | 102 |
| 5-19Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 2 |
| 5-19Y, DOM *, Missing/NA | 300 | 61 | 21 | 27 | 1024 |
| 5-19Y, MH in the last 3 months, Yes | 5 | 1 | 1 | 1 | 19 |
| 5-19Y, MH in the last 3 months, No | 328 | 70 | 28 | 35 | 1139 |
| 20Y+, MT in past 14 days, Yes | 2 | 0 | 0 | 2 | 84 |
| 20Y+, MT in past 14 days, No | 122 | 10 | 5 | 5 | 1357 |
| 20Y+, EDMT *, Ongoing | 0 | 0 | 0 | 1 | 5 |
| 20Y+, EDMT *, 1-3 days | 2 | 0 | 0 | 1 | 72 |
| 20Y+, EDMT *, ≥ 4days | 0 | 0 | 0 | 0 | 7 |
| 20Y+, EDMT *, Missing/NA | 122 | 10 | 5 | 5 | 1357 |
| 20Y+, OM in past 14 days, Yes | 10 | 2 | 2 | 3 | 214 |
| 20Y+, OM in past 14 days, No | 114 | 8 | 3 | 4 | 1227 |
| 20Y+, DOM *, Ongoing | 1 | 0 | 1 | 2 | 71 |
| 20Y+, DOM *, 1-7 days | 9 | 2 | 1 | 1 | 138 |
| 20Y+, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 5 |
| 20Y+, DOM *, Missing/NA | 114 | 8 | 3 | 4 | 1227 |
| 20Y+, MH in the last 3 months, Yes | 1 | 1 | 0 | 0 | 19 |
| 20Y+, MH in the last 3 months, No | 123 | 9 | 5 | 7 | 1422 |
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, MT in past 14 days, Yes | 17 | 13 | 3 | 9 | 267 |
| 6M-4Y, MT in past 14 days, No | 262 | 148 | 71 | 82 | 2321 |
| 6M-4Y, EDMT *, Ongoing | 4 | 1 | 0 | 4 | 33 |
| 6M-4Y, EDMT *, 1-3 days | 11 | 10 | 3 | 5 | 210 |
| 6M-4Y, EDMT *, ≥ 4days | 2 | 2 | 0 | 0 | 24 |
| 6M-4Y, EDMT *, Missing/NA | 262 | 148 | 71 | 82 | 2321 |
| 6M-4Y, OM in past 14 days, Yes | 65 | 30 | 18 | 18 | 547 |
| 6M-4Y, OM in past 14 days, No | 214 | 131 | 56 | 73 | 2041 |
| 6M-4Y, DOM *, Ongoing | 10 | 8 | 3 | 6 | 142 |
| 6M-4Y, DOM *, 1-7 days | 55 | 22 | 15 | 12 | 394 |
| 6M-4Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 11 |
| 6M-4Y, DOM *, Missing/NA | 214 | 131 | 56 | 73 | 2041 |
| 6M-4Y, MH in the last 3 months, Yes | 14 | 4 | 3 | 0 | 99 |
| 6M-4Y, MH in the last 3 months, No | 265 | 157 | 71 | 91 | 2489 |
| 5-19Y, MT in past 14 days, Yes | 14 | 4 | 1 | 1 | 58 |
| 5-19Y, MT in past 14 days, No | 327 | 90 | 12 | 34 | 1071 |
| 5-19Y, EDMT *, Ongoing | 4 | 1 | 0 | 0 | 4 |
| 5-19Y, EDMT *, 1-3 days | 8 | 3 | 1 | 1 | 50 |
| 5-19Y, EDMT *, ≥ 4days | 2 | 0 | 0 | 0 | 4 |
| 5-19Y, EDMT *, Missing/NA | 327 | 90 | 12 | 34 | 1071 |
| 5-19Y, OM in past 14 days, Yes | 44 | 18 | 3 | 13 | 128 |
| 5-19Y, OM in past 14 days, No | 297 | 76 | 10 | 22 | 1001 |
| 5-19Y, DOM *, Ongoing | 13 | 1 | 0 | 2 | 19 |
| 5-19Y, DOM *, 1-7 days | 31 | 17 | 3 | 11 | 109 |
| 5-19Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, DOM *, Missing/NA | 297 | 76 | 10 | 22 | 1001 |
| 5-19Y, MH in the last 3 months, Yes | 7 | 0 | 0 | 1 | 17 |
| 5-19Y, MH in the last 3 months, No | 334 | 94 | 13 | 34 | 1112 |
| 20Y+, MT in past 14 days, Yes | 5 | 2 | 0 | 0 | 70 |
| 20Y+, MT in past 14 days, No | 166 | 11 | 5 | 4 | 1332 |
| 20Y+, EDMT *, Ongoing | 0 | 0 | 0 | 0 | 6 |
| 20Y+, EDMT *, 1-3 days | 5 | 1 | 0 | 0 | 63 |
| 20Y+, EDMT *, ≥ 4days | 0 | 1 | 0 | 0 | 1 |
| 20Y+, EDMT *, Missing/NA | 166 | 11 | 5 | 4 | 1332 |
| 20Y+, OM in past 14 days, Yes | 25 | 3 | 3 | 1 | 227 |
| 20Y+, OM in past 14 days, No | 146 | 10 | 2 | 3 | 1175 |
| 20Y+, DOM *, Ongoing | 5 | 3 | 0 | 1 | 70 |
| 20Y+, DOM *, 1-7 days | 19 | 0 | 3 | 0 | 151 |
| 20Y+, DOM *, ≥ 8 days | 1 | 0 | 0 | 0 | 6 |
| 20Y+, DOM *, Missing/NA | 146 | 10 | 2 | 3 | 1175 |
| 20Y+, MH in the last 3 months, Yes | 0 | 0 | 0 | 0 | 12 |
| 20Y+, MH in the last 3 months, No | 171 | 13 | 5 | 4 | 1390 |
The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.\* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, MT in past 14 days, Yes | 5 | 2 | 1 | 5 | 71 |
| 6M-4Y, MT in past 14 days, No | 163 | 101 | 19 | 49 | 777 |
| 6M-4Y, EDMT *, Ongoing | 2 | 1 | 0 | 4 | 21 |
| 6M-4Y, EDMT *, 1-3 days | 3 | 1 | 1 | 1 | 49 |
| 6M-4Y, EDMT *, ≥ 4days | 0 | 0 | 0 | 0 | 1 |
| 6M-4Y, EDMT *, Missing/NA | 163 | 101 | 19 | 49 | 777 |
| 6M-4Y, OM in past 14 days, Yes | 21 | 11 | 7 | 12 | 152 |
| 6M-4Y, OM in past 14 days, No | 147 | 92 | 13 | 42 | 696 |
| 6M-4Y, DOM *, Ongoing | 5 | 2 | 3 | 5 | 48 |
| 6M-4Y, DOM *, 1-7 days | 16 | 8 | 4 | 7 | 103 |
| 6M-4Y, DOM *, ≥ 8 days | 0 | 1 | 0 | 0 | 1 |
| 6M-4Y, DOM *, Missing/NA | 147 | 92 | 13 | 42 | 696 |
| 6M-4Y, MH in the last 3 months, Yes | 9 | 1 | 0 | 2 | 28 |
| 6M-4Y, MH in the last 3 months, No | 159 | 102 | 20 | 52 | 820 |
| 5-19Y, MT in past 14 days, Yes | 2 | 0 | 0 | 0 | 10 |
| 5-19Y, MT in past 14 days, No | 196 | 51 | 16 | 13 | 318 |
| 5-19Y, EDMT *, Ongoing | 0 | 0 | 0 | 0 | 3 |
| 5-19Y, EDMT *, 1-3 days | 2 | 0 | 0 | 0 | 7 |
| 5-19Y, EDMT *, ≥ 4days | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, EDMT *, Missing/NA | 196 | 51 | 16 | 13 | 318 |
| 5-19Y, OM in past 14 days, Yes | 13 | 4 | 0 | 2 | 28 |
| 5-19Y, OM in past 14 days, No | 185 | 47 | 16 | 11 | 300 |
| 5-19Y, DOM *, Ongoing | 1 | 0 | 0 | 1 | 6 |
| 5-19Y, DOM *, 1-7 days | 12 | 4 | 0 | 1 | 22 |
| 5-19Y, DOM *, ≥ 8 days | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, DOM *, Missing/NA | 185 | 47 | 16 | 11 | 300 |
| 5-19Y, MH in the last 3 months, Yes | 0 | 0 | 0 | 0 | 2 |
| 5-19Y, MH in the last 3 months, No | 198 | 51 | 16 | 13 | 326 |
| 20Y+, MT in past 14 days, Yes | 1 | 0 | — | 0 | 8 |
| 20Y+, MT in past 14 days, No | 86 | 4 | — | 1 | 500 |
| 20Y+, EDMT *, Ongoing | 0 | 0 | — | 0 | 1 |
| 20Y+, EDMT *, 1-3 days | 1 | 0 | — | 0 | 5 |
| 20Y+, EDMT *, ≥ 4days | 0 | 0 | — | 0 | 2 |
| 20Y+, EDMT *, Missing/NA | 86 | 4 | — | 1 | 500 |
| 20Y+, OM in past 14 days, Yes | 5 | 0 | — | 0 | 57 |
| 20Y+, OM in past 14 days, No | 82 | 4 | — | 1 | 451 |
| 20Y+, DOM *, Ongoing | 1 | 0 | — | 0 | 18 |
| 20Y+, DOM *, 1-7 days | 4 | 0 | — | 0 | 36 |
| 20Y+, DOM *, ≥ 8 days | 0 | 0 | — | 0 | 3 |
| 20Y+, DOM *, Missing/NA | 82 | 4 | — | 1 | 451 |
| 20Y+, MH in the last 3 months, Yes | 0 | 0 | — | 0 | 5 |
| 20Y+, MH in the last 3 months, No | 87 | 4 | — | 1 | 503 |
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, DMT | 2.6 ± 1.02 | 3.7 ± 1.70 | 2.5 ± 0.71 | 3.1 ± 0.67 | 3.1 ± 1.45 |
| 5-19Y, DMT | 2.0 ± 0.82 | 2.2 ± 0.98 | 2.8 ± 0.50 | 3.5 ± 0.71 | 2.5 ± 1.09 |
| 20+Y, DMT | 1.0 ± 0.00 | — | — | — | 2.6 ± 1.37 |
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, DMT | 2.8 ± 1.48 | 5.7 ± 2.31 | 3.5 ± 0.71 | 2.0 ± 1.15 | 3.1 ± 1.16 |
| 5-19Y, DMT | 2.8 ± 1.81 | 3.5 ± 2.12 | 3.0 ± 0.00 | 2.5 ± 1.00 | 2.5 ± 0.81 |
| 20+Y, DMT | 3.0 ± 0.00 | — | — | 1.0 ± 0.00 | 2.5 ± 1.37 |
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, DMT | 3.0 ± 0.71 | 3.3 ± 1.07 | 2.3 ± 1.15 | 2.2 ± 1.10 | 3.1 ± 1.08 |
| 5-19Y, DMT | 3.9 ± 2.88 | 1.7 ± 1.15 | 3.0 ± 0.00 | 1.0 ± 0.00 | 2.9 ± 1.27 |
| 20+Y, DMT | 1.4 ± 0.89 | 5.0 ± 2.83 | — | — | 2.3 ± 1.12 |
The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, DMT | 2.3 ± 1.15 | 3.0 ± 0.00 | 3.0 ± 0.00 | 1.0 ± 0.00 | 3.1 ± 0.59 |
| 5-19Y, DMT | 3.0 ± 0.00 | — | — | — | 2.9 ± 0.38 |
| 20+Y, DMT | 1.0 ± 0.00 | — | — | — | 3.3 ± 2.14 |
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, F 24h - Yes | 71 | 53 | 21 | 60 | 361 |
| 6M-4Y, F 24h - No | 302 | 117 | 37 | 59 | 2119 |
| 6M-4Y, F at V - Yes | 26 | 13 | 7 | 22 | 79 |
| 6M-4Y, F at V - No | 347 | 157 | 51 | 97 | 2400 |
| 6M-4Y, F at V - Missing/NA | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, F 24h - Yes | 37 | 25 | 10 | 24 | 124 |
| 5-19Y, F 24h - No | 257 | 46 | 13 | 34 | 1043 |
| 5-19Y, F at V - Yes | 6 | 5 | 5 | 17 | 29 |
| 5-19Y, F at V - No | 288 | 66 | 18 | 41 | 1138 |
| 20+Y, F 24h - Yes | 30 | 9 | — | 2 | 181 |
| 20+Y, F 24h - No | 89 | 8 | — | 9 | 1260 |
| 20+Y, F at V - Yes | 3 | 0 | — | 1 | 23 |
| 20+Y, F at V - No | 115 | 17 | — | 10 | 1418 |
| 20+Y, F at V - Missing/NA | 1 | 0 | — | 0 | 0 |
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, F 24h - Yes | 41 | 23 | 15 | 35 | 357 |
| 6M-4Y, F 24h - No | 242 | 125 | 52 | 41 | 2266 |
| 6M-4Y, F at V - Yes | 26 | 16 | 15 | 29 | 98 |
| 6M-4Y, F at V - No | 257 | 132 | 52 | 47 | 2525 |
| 5-19Y, F 24h - Yes | 39 | 11 | 11 | 13 | 115 |
| 5-19Y, F 24h - No | 294 | 60 | 18 | 23 | 1043 |
| 5-19Y, F at V - Yes | 24 | 4 | 3 | 8 | 26 |
| 5-19Y, F at V - No | 309 | 67 | 26 | 28 | 1132 |
| 20+Y, F 24h - Yes | 14 | 4 | 3 | 2 | 169 |
| 20+Y, F 24h - No | 110 | 6 | 2 | 5 | 1272 |
| 20+Y, F at V - Yes | 10 | 0 | 0 | 1 | 36 |
| 20+Y, F at V - No | 114 | 10 | 5 | 6 | 1404 |
| 20+Y, F at V - Missing/NA | 0 | 0 | 0 | 0 | 1 |
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, F 24h - Yes | 60 | 44 | 28 | 44 | 360 |
| 6M-4Y, F 24h - No | 219 | 117 | 46 | 47 | 2228 |
| 6M-4Y, F at V - Yes | 8 | 16 | 9 | 22 | 56 |
| 6M-4Y, F at V - No | 271 | 145 | 65 | 69 | 2532 |
| 5-19Y, F 24h - Yes | 54 | 25 | 4 | 17 | 92 |
| 5-19Y, F 24h - No | 287 | 69 | 9 | 18 | 1037 |
| 5-19Y, F at V - Yes | 11 | 6 | 1 | 14 | 21 |
| 5-19Y, F at V - No | 330 | 87 | 12 | 21 | 1107 |
| 5-19Y, F at V - Missing/NA | 0 | 1 | 0 | 0 | 1 |
| 20+Y, F 24h - Yes | 20 | 4 | 4 | 1 | 167 |
| 20+Y, F 24h - No | 151 | 9 | 1 | 3 | 1235 |
| 20+Y, F at V - Yes | 5 | 0 | 3 | 1 | 23 |
| 20+Y, F at V - No | 166 | 13 | 2 | 3 | 1378 |
| 20+Y, F at V - Missing/NA | 0 | 0 | 0 | 0 | 1 |
Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, F 24h - Yes | 39 | 18 | 5 | 27 | 115 |
| 6M-4Y, F 24h - No | 129 | 85 | 15 | 27 | 733 |
| 6M-4Y, F at V - Yes | 8 | 8 | 4 | 18 | 20 |
| 6M-4Y, F at V - No | 160 | 95 | 16 | 36 | 827 |
| 6M-4Y, F at V - Missing/NA | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, F 24h - Yes | 38 | 8 | 4 | 4 | 22 |
| 5-19Y, F 24h - No | 160 | 43 | 12 | 9 | 306 |
| 5-19Y, F at V - Yes | 5 | 0 | 2 | 1 | 4 |
| 5-19Y, F at V - No | 193 | 51 | 14 | 12 | 324 |
| 20+Y, F 24h - Yes | 11 | 0 | — | 0 | 25 |
| 20+Y, F 24h - No | 76 | 4 | — | 1 | 483 |
| 20+Y, F at V - Yes | 0 | 0 | — | 0 | 3 |
| 20+Y, F at V - No | 87 | 4 | — | 1 | 505 |
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, DaFs | 2.5 ± 2.18 | 2.6 ± 2.23 | 2.1 ± 1.42 | 2.5 ± 4.13 | 2.3 ± 1.77 |
| 5-19Y, DaFs | 2.2 ± 1.41 | 2.2 ± 1.29 | 2.7 ± 2.06 | 1.7 ± 1.05 | 2.3 ± 1.93 |
| 20+Y, DaFs | 2.3 ± 1.56 | 2.3 ± 1.87 | — | 2.5 ± 0.71 | 2.9 ± 3.36 |
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, DaFs | 2.1 ± 1.35 | 2.7 ± 1.99 | 1.4 ± 0.51 | 2.0 ± 1.46 | 2.4 ± 1.76 |
| 5-19Y, DaFs | 2.5 ± 1.62 | 2.6 ± 2.38 | 2.5 ± 2.34 | 2.1 ± 1.80 | 2.1 ± 1.38 |
| 20+Y, DaFs | 4.0 ± 3.64 | 2.0 ± 1.15 | 2.0 ± 1.00 | 4.0 ± 2.83 | 3.2 ± 2.96 |
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, DaFs | 2.3 ± 1.90 | 2.4 ± 1.95 | 2.2 ± 1.33 | 2.1 ± 1.37 | 2.5 ± 1.80 |
| 5-19Y, DaFs | 2.3 ± 1.58 | 2.8 ± 1.63 | 2.5 ± 1.73 | 1.8 ± 0.53 | 2.7 ± 2.21 |
| 20+Y, DaFs | 3.0 ± 1.81 | 2.8 ± 0.50 | 3.8 ± 2.22 | 3.0 ± 0.00 | 3.3 ± 4.28 |
The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Days | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, DaFs | 2.2 ± 1.05 | 2.4 ± 2.43 | 1.6 ± 0.89 | 2.2 ± 1.64 | 2.7 ± 1.88 |
| 5-19Y, DaFs | 2.0 ± 0.97 | 3.8 ± 2.38 | 1.5 ± 0.58 | 2.0 ± 1.15 | 2.1 ± 1.23 |
| 20+Y, DaFs | 2.5 ± 1.21 | — | — | — | 3.2 ± 1.38 |
The mean and standard deviation of the axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Degrees Celsius | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, A temp. at V | 36.65 ± 0.521 | 36.64 ± 0.623 | 36.72 ± 0.782 | 37.04 ± 0.803 | 36.55 ± 0.522 |
| 5-19Y, A temp. at V | 36.56 ± 0.469 | 36.70 ± 0.597 | 37.07 ± 0.853 | 37.29 ± 0.928 | 36.63 ± 0.496 |
| 20+Y, A temp. at V | 36.55 ± 0.459 | 36.70 ± 0.387 | — | 36.82 ± 0.462 | 36.60 ± 0.478 |
The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Degrees Celsius | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, A temp. at V | 36.69 ± 0.574 | 36.75 ± 0.628 | 36.86 ± 0.725 | 37.41 ± 1.201 | 36.60 ± 0.479 |
| 5-19Y, A temp. at V | 36.70 ± 0.522 | 36.76 ± 0.507 | 36.76 ± 0.773 | 37.36 ± 0.949 | 36.66 ± 0.447 |
| 20+Y, A temp. at V | 36.70 ± 0.478 | 36.75 ± 0.375 | 36.64 ± 0.559 | 37.09 ± 0.713 | 36.67 ± 0.430 |
The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Degrees Celsius | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, A temp. at V | 36.47 ± 0.517 | 36.66 ± 0.652 | 36.68 ± 0.701 | 36.97 ± 0.951 | 36.54 ± 0.496 |
| 5-19Y, A temp. at V | 36.56 ± 0.551 | 36.66 ± 0.571 | 36.61 ± 0.475 | 37.45 ± 1.117 | 36.59 ± 0.462 |
| 20+Y, A temp. at V | 36.44 ± 0.515 | 36.42 ± 0.409 | 37.54 ± 1.135 | 37.18 ± 0.727 | 36.55 ± 0.493 |
The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Degrees Celsius | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, A temp. at V | 36.51 ± 0.508 | 36.51 ± 0.535 | 36.95 ± 0.927 | 37.16 ± 1.187 | 36.40 ± 0.492 |
| 5-19Y, A temp. at V | 36.53 ± 0.510 | 36.55 ± 0.379 | 36.53 ± 0.570 | 36.61 ± 0.431 | 36.38 ± 0.430 |
| 20+Y, A temp. at V | 36.42 ± 0.444 | 36.68 ± 0.206 | — | 36.50 ± 0.000 | 36.39 ± 0.457 |
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH/PES, <3/1 | 34 | 13 | 3 | 2 | 78 |
| 6M-4Y, PLSPH/PES, 4-5/1 | 32 | 15 | 1 | 2 | 146 |
| 6M-4Y, PLSPH/PES, >5/1 | 20 | 10 | 0 | 3 | 123 |
| 6M-4Y, PLSPH/PES, <3/2 | 46 | 14 | 6 | 14 | 280 |
| 6M-4Y, PLSPH/PES, 4-5/2 | 106 | 49 | 13 | 36 | 737 |
| 6M-4Y, PLSPH/PES, >5/2 | 119 | 59 | 28 | 59 | 1038 |
| 6M-4Y, PLSPH/PES, <3/3 | 1 | 0 | 0 | 0 | 3 |
| 6M-4Y, PLSPH/PES, 4-5/3 | 1 | 1 | 1 | 1 | 19 |
| 6M-4Y, PLSPH/PES, >5/3 | 13 | 7 | 4 | 1 | 45 |
| 6M-4Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 1 | 0 | 1 |
| 6M-4Y, PLSPH/PES, >5/>3 | 1 | 2 | 1 | 1 | 9 |
| 6M-4Y, Missing | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, PLSPH/PES, <3/1 | 20 | 6 | 0 | 0 | 28 |
| 5-19Y, PLSPH/PES, 4-5/1 | 14 | 2 | 1 | 1 | 17 |
| 5-19Y, PLSPH/PES, >5/1 | 8 | 3 | 1 | 0 | 37 |
| 5-19Y, PLSPH/PES, <3/2 | 19 | 4 | 1 | 5 | 75 |
| 5-19Y, PLSPH/PES, 4-5/2 | 76 | 13 | 9 | 17 | 357 |
| 5-19Y, PLSPH/PES, >5/2 | 111 | 38 | 10 | 34 | 560 |
| 5-19Y, PLSPH/PES, <3/3 | 0 | 1 | 0 | 0 | 2 |
| 5-19Y, PLSPH/PES, 4-5/3 | 10 | 1 | 0 | 0 | 14 |
| 5-19Y, PLSPH/PES, >5/3 | 25 | 2 | 1 | 1 | 59 |
| 5-19Y, PLSPH/PES, 4-5/>3 | 1 | 0 | 0 | 0 | 0 |
| 5-19Y, PLSPH/PES, >5/>3 | 10 | 1 | 0 | 0 | 17 |
| 5-19Y, Missing | 0 | 0 | 0 | 0 | 1 |
| 20+Y, PLSPH/PES, <3/1 | 3 | 0 | — | 0 | 49 |
| 20+Y, PLSPH/PES, 4-5/1 | 1 | 0 | — | 0 | 16 |
| 20+Y, PLSPH/PES, >5/1 | 6 | 1 | — | 0 | 26 |
| 20+Y, PLSPH/PES, <3/2 | 22 | 2 | — | 2 | 234 |
| 20+Y, PLSPH/PES, 4-5/2 | 40 | 7 | — | 3 | 449 |
| 20+Y, PLSPH/PES, >5/2 | 33 | 7 | — | 6 | 575 |
| 20+Y, PLSPH/PES, <3/3 | 0 | 0 | — | 0 | 2 |
| 20+Y, PLSPH/PES, 4-5/3 | 3 | 0 | — | 0 | 18 |
| 20+Y, PLSPH/PES, >5/3 | 10 | 0 | — | 0 | 51 |
| 20+Y, PLSPH/PES, 4-5/>3 | 0 | 0 | — | 0 | 1 |
| 20+Y, PLSPH/PES, >5/>3 | 1 | 0 | — | 0 | 18 |
| 20+Y, Missing | 0 | 0 | — | 0 | 2 |
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH/PES, <3/1 | 27 | 18 | 8 | 2 | 59 |
| 6M-4Y, PLSPH/PES, 4-5/1 | 33 | 18 | 8 | 3 | 112 |
| 6M-4Y, PLSPH/PES, >5/1 | 13 | 9 | 3 | 4 | 84 |
| 6M-4Y, PLSPH/PES, <3/2 | 37 | 21 | 8 | 14 | 306 |
| 6M-4Y, PLSPH/PES, 4-5/2 | 93 | 48 | 17 | 24 | 964 |
| 6M-4Y, PLSPH/PES, >5/2 | 76 | 32 | 19 | 27 | 1059 |
| 6M-4Y, PLSPH/PES, <3/3 | 1 | 0 | 0 | 0 | 2 |
| 6M-4Y, PLSPH/PES, 4-5/3 | 0 | 0 | 0 | 0 | 11 |
| 6M-4Y, PLSPH/PES, >5/3 | 3 | 1 | 4 | 2 | 24 |
| 6M-4Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 2 |
| 6M-4Y, PLSPH/PES, >5/>3 | 0 | 1 | 0 | 0 | 0 |
| 5-19Y, PLSPH/PES, <3/1 | 34 | 3 | 1 | 3 | 23 |
| 5-19Y, PLSPH/PES, 4-5/1 | 30 | 13 | 2 | 0 | 20 |
| 5-19Y, PLSPH/PES, >5/1 | 16 | 3 | 0 | 0 | 38 |
| 5-19Y, PLSPH/PES, <3/2 | 30 | 3 | 0 | 2 | 69 |
| 5-19Y, PLSPH/PES, 4-5/2 | 98 | 17 | 10 | 13 | 426 |
| 5-19Y, PLSPH/PES, >5/2 | 105 | 28 | 15 | 17 | 548 |
| 5-19Y, PLSPH/PES, <3/3 | 2 | 0 | 0 | 0 | 1 |
| 5-19Y, PLSPH/PES, 4-5/3 | 4 | 0 | 0 | 0 | 9 |
| 5-19Y, PLSPH/PES, >5/3 | 14 | 4 | 1 | 1 | 20 |
| 5-19Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 4 |
| 5-19Y, PLSPH/PES, >5/>3 | 0 | 0 | 0 | 0 | 0 |
| 20+Y, PLSPH-PES, <3/1 | 14 | 0 | 0 | 0 | 40 |
| 20+Y, PLSPH/PES, 4-5/1 | 8 | 0 | 0 | 0 | 26 |
| 20+Y, PLSPH/PES, >5/1 | 5 | 0 | 1 | 0 | 51 |
| 20+Y, PLSPH/PES, <3/2 | 34 | 2 | 1 | 2 | 253 |
| 20+Y, PLSPH/PES, 4-5/2 | 39 | 3 | 0 | 2 | 553 |
| 20+Y, PLSPH/PES, >5/2 | 21 | 5 | 3 | 3 | 476 |
| 20+Y, PLSPH/PES, <3/3 | 0 | 0 | 0 | 0 | 3 |
| 20+Y, PLSPH/PES, 4-5/3 | 0 | 0 | 0 | 0 | 9 |
| 20+Y, PLSPH/PES, >5/3 | 3 | 0 | 0 | 0 | 25 |
| 20+Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 2 |
| 20+Y, PLSPH/PES, >5/>3 | 0 | 0 | 0 | 0 | 3 |
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH/PES, <3/1 | 31 | 16 | 7 | 11 | 63 |
| 6M-4Y, PLSPH/PES, 4-5/1 | 31 | 26 | 8 | 11 | 94 |
| 6M-4Y, PLSPH/PES, >5/1 | 15 | 10 | 6 | 2 | 94 |
| 6M-4Y, PLSPH/PES, <3/2 | 43 | 24 | 13 | 17 | 340 |
| 6M-4Y, PLSPH/PES, 4-5/2 | 76 | 30 | 19 | 22 | 973 |
| 6M-4Y, PLSPH/PES, >5/2 | 75 | 44 | 19 | 26 | 984 |
| 6M-4Y, PLSPH/PES, <3/3 | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, PLSPH/PES, 4-5/3 | 2 | 0 | 1 | 0 | 11 |
| 6M-4Y, PLSPH/PES, >5/3 | 6 | 11 | 1 | 2 | 29 |
| 6M-4Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, PLSPH/PES, >5/>3 | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, PLSPH/PES, <3/1 | 40 | 9 | 1 | 1 | 24 |
| 5-19Y, PLSPH/PES, 4-5/1 | 32 | 8 | 0 | 1 | 23 |
| 5-19Y, PLSPH/PES, >5/1 | 31 | 1 | 0 | 3 | 42 |
| 5-19Y, PLSPH/PES, <3/2 | 24 | 13 | 0 | 2 | 88 |
| 5-19Y, PLSPH/PES, 4-5/2 | 74 | 25 | 5 | 13 | 421 |
| 5-19Y, PLSPH/PES, >5/2 | 103 | 36 | 7 | 15 | 507 |
| 5-19Y, PLSPH/PES, <3/3 | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, PLSPH/PES, 4-5/3 | 7 | 0 | 0 | 0 | 7 |
| 5-19Y, PLSPH/PES, >5/3 | 30 | 2 | 0 | 0 | 17 |
| 5-19Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, PLSPH/PES, >5/>3 | 0 | 0 | 0 | 0 | 0 |
| 20+Y, PLSPH/PES, <3/1 | 18 | 0 | 0 | 0 | 40 |
| 20+Y, PLSPH/PES, 4-5/1 | 7 | 0 | 0 | 0 | 27 |
| 20+Y, PLSPH/PES, >5/1 | 5 | 0 | 0 | 0 | 33 |
| 20+Y, PLSPH/PES, <3/2 | 43 | 3 | 0 | 1 | 273 |
| 20+Y, PLSPH/PES, 4-5/2 | 57 | 4 | 3 | 0 | 516 |
| 20+Y, PLSPH/PES, >5/2 | 28 | 6 | 2 | 3 | 463 |
| 20+Y, PLSPH/PES, <3/3 | 0 | 0 | 0 | 0 | 0 |
| 20+Y, PLSPH/PES, 4-5/3 | 0 | 0 | 0 | 0 | 14 |
| 20+Y, PLSPH/PES, >5/3 | 13 | 0 | 0 | 0 | 36 |
| 20+Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 0 |
| 20+Y, PLSPH/PES, >5/>3 | 0 | 0 | 0 | 0 | 0 |
The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: \< y/x (less than \[\<\] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), \> z/x (more than \[\>\] z PLSPH among x PES), y-z/\> x (y to z PLSPH among more than \[\>\] x PES), \> z/\> x (more than \[\>\] z PLSPH among more than \[\>\] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH/PES, <3/1 | 28 | 21 | 2 | 7 | 42 |
| 6M-4Y, PLSPH/PES, 4-5/1 | 24 | 14 | 4 | 5 | 74 |
| 6M-4Y, PLSPH/PES, >5/1 | 18 | 7 | 1 | 5 | 59 |
| 6M-4Y, PLSPH/PES, <3/2 | 27 | 18 | 3 | 10 | 74 |
| 6M-4Y, PLSPH/PES, 4-5/2 | 30 | 23 | 3 | 13 | 184 |
| 6M-4Y, PLSPH/PES, >5/2 | 25 | 12 | 4 | 12 | 338 |
| 6M-4Y, PLSPH-PES, <3/3 | 0 | 0 | 1 | 0 | 1 |
| 6M-4Y, PLSPH/PES, 4-5/3 | 1 | 1 | 0 | 1 | 9 |
| 6M-4Y, PLSPH/PES, >5/3 | 14 | 7 | 2 | 1 | 62 |
| 6M-4Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 1 |
| 6M-4Y, PLSPH/PES, >5/>3 | 1 | 0 | 0 | 0 | 4 |
| 5-19Y, PLSPH/PES, <3/1 | 36 | 5 | 2 | 2 | 17 |
| 5-19Y, PLSPH/PES, 4-5/1 | 35 | 11 | 1 | 2 | 23 |
| 5-19Y, PLSPH/PES, >5/1 | 4 | 2 | 2 | 1 | 7 |
| 5-19Y, PLSPH/PES, <3/2 | 13 | 5 | 2 | 0 | 10 |
| 5-19Y, PLSPH/PES, 4-5/2 | 27 | 8 | 3 | 3 | 65 |
| 5-19Y, PLSPH/PES, >5/2 | 31 | 10 | 3 | 4 | 149 |
| 5-19Y, PLSPH/PES, <3/3 | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, PLSPH/PES, 4-5/3 | 5 | 1 | 0 | 0 | 12 |
| 5-19Y, PLSPH/PES, >5/3 | 42 | 9 | 3 | 1 | 38 |
| 5-19Y, PLSPH/PES, 4-5/>3 | 0 | 0 | 0 | 0 | 2 |
| 5-19Y, PLSPH/PES, >5/>3 | 5 | 0 | 0 | 0 | 5 |
| 20+Y, PLSPH/PES, <3/1 | 4 | 0 | — | 0 | 20 |
| 20+Y, PLSPH/PES, 4-5/1 | 4 | 0 | — | 0 | 8 |
| 20+Y, PLSPH/PES, >5/1 | 1 | 0 | — | 0 | 10 |
| 20+Y, PLSPH/PES, <3/2 | 23 | 0 | — | 0 | 81 |
| 20+Y, PLSPH/PES, 4-5/2 | 26 | 2 | — | 0 | 119 |
| 20+Y, PLSPH/PES, >5/2 | 15 | 1 | — | 0 | 191 |
| 20+Y, PLSPH/PES, <3/3 | 1 | 0 | — | 0 | 3 |
| 20+Y, PLSPH/PES, 4-5/3 | 2 | 0 | — | 1 | 3 |
| 20+Y, PLSPH/PES, >5/3 | 11 | 1 | — | 0 | 67 |
| 20+Y, PLSPH/PES, 4-5/>3 | 0 | 0 | — | 0 | 1 |
| 20+Y, PLSPH/PES, >5/>3 | 0 | 0 | — | 0 | 5 |
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Persons | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH | 6.4 ± 4.83 | 6.3 ± 4.23 | 6.5 ± 3.98 | 5.8 ± 2.14 | 6.5 ± 4.28 |
| 5-19Y, PLSPH | 6.9 ± 4.55 | 6.6 ± 3.53 | 5.9 ± 1.91 | 6.5 ± 3.04 | 7.1 ± 4.69 |
| 20+Y, PLSPH | 6.1 ± 4.15 | 7.4 ± 5.21 | — | 6.2 ± 2.99 | 6.3 ± 4.24 |
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Persons | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH | 5.1 ± 2.90 | 5.0 ± 2.17 | 5.1 ± 2.34 | 5.4 ± 2.62 | 5.8 ± 2.66 |
| 5-19Y, PLSPH | 5.5 ± 2.64 | 6.1 ± 2.78 | 5.9 ± 1.89 | 5.9 ± 2.81 | 6.2 ± 2.78 |
| 20+Y, PLSPH | 4.7 ± 3.35 | 6.5 ± 3.24 | 7.8 ± 3.27 | 5.3 ± 2.56 | 5.4 ± 2.64 |
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Persons | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH | 5.1 ± 2.73 | 5.4 ± 2.74 | 5.1 ± 3.40 | 5.0 ± 2.43 | 5.6 ± 2.48 |
| 5-19Y, PLSPH | 5.9 ± 3.25 | 5.1 ± 2.04 | 5.5 ± 1.85 | 5.8 ± 2.06 | 6.0 ± 2.42 |
| 20+Y, PLSPH | 4.5 ± 2.16 | 5.9 ± 3.23 | 5.4 ± 1.14 | 6.5 ± 2.89 | 5.4 ± 2.77 |
The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Persons | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, PLSPH | 5.4 ± 3.12 | 5.1 ± 3.73 | 5.5 ± 3.50 | 5.2 ± 3.24 | 6.6 ± 3.33 |
| 5-19Y, PLSPH | 6.5 ± 4.55 | 6.1 ± 3.95 | 6.3 ± 3.13 | 6.8 ± 4.28 | 7.3 ± 3.70 |
| 20+Y, PLSPH | 5.0 ± 2.94 | 6.3 ± 2.22 | — | 5.0 ± 0.00 | 6.6 ± 3.96 |
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural or missing) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants or missing type of location). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, rural | 309 | 136 | 45 | 106 | 1415 |
| 6M-4Y, urban | 39 | 22 | 10 | 11 | 803 |
| 6M-4Y, semi-rural | 25 | 12 | 3 | 2 | 262 |
| 6M-4Y, missing - localisation | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, large city | 18 | 14 | 7 | 7 | 355 |
| 6M-4Y, small city | 0 | 0 | 0 | 0 | 18 |
| 6M-4Y, town | 44 | 16 | 5 | 6 | 644 |
| 6M-4Y, countryside | 311 | 140 | 46 | 106 | 1463 |
| 5-19Y, rural | 225 | 55 | 16 | 51 | 688 |
| 5-19Y, urban | 50 | 13 | 4 | 5 | 350 |
| 5-19Y, semi-rural | 19 | 3 | 3 | 2 | 128 |
| 5-19Y, missing - localisation | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, large city | 25 | 5 | 4 | 4 | 162 |
| 5-19Y, small city | 1 | 0 | 0 | 0 | 7 |
| 5-19Y, town | 43 | 11 | 2 | 3 | 282 |
| 5-19Y, countryside | 225 | 55 | 17 | 51 | 715 |
| 5-19Y, missing - type of localisation | 0 | 0 | 0 | 0 | 1 |
| 20+Y, rural | 89 | 12 | — | 10 | 923 |
| 20+Y, urban | 26 | 3 | — | 0 | 370 |
| 20+Y, semi-rural | 4 | 2 | — | 1 | 147 |
| 20+Y, missing - localisation | 0 | 0 | — | 0 | 1 |
| 20+Y, large city | 16 | 3 | — | 0 | 181 |
| 20+Y, small city | 0 | 0 | — | 0 | 9 |
| 20+Y, town | 14 | 2 | — | 1 | 299 |
| 20+Y, countryside | 89 | 12 | — | 10 | 951 |
| 20+Y, missing - type of localisation | 0 | 0 | — | 0 | 1 |
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, rural | 212 | 120 | 51 | 60 | 1377 |
| 6M-4Y, urban | 44 | 16 | 14 | 15 | 995 |
| 6M-4Y, semi-rural | 27 | 12 | 2 | 1 | 251 |
| 6M-4Y, large city | 10 | 4 | 5 | 6 | 374 |
| 6M-4Y, small city | 0 | 0 | 0 | 0 | 6 |
| 6M-4Y, town | 34 | 12 | 9 | 9 | 632 |
| 6M-4Y, countryside | 239 | 132 | 53 | 61 | 1611 |
| 5-19Y, rural | 237 | 48 | 17 | 25 | 583 |
| 5-19Y, urban | 72 | 22 | 11 | 10 | 472 |
| 5-19Y, semi-rural | 24 | 1 | 1 | 1 | 103 |
| 5-19Y, large city | 15 | 5 | 2 | 7 | 172 |
| 5-19Y, small city | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, town | 57 | 17 | 9 | 3 | 305 |
| 5-19Y, countryside | 261 | 49 | 18 | 26 | 680 |
| 20+Y, rural | 94 | 6 | 2 | 6 | 769 |
| 20+Y, urban | 26 | 4 | 3 | 1 | 515 |
| 20+Y, semi-rural | 4 | 0 | 0 | 0 | 157 |
| 20+Y, large city | 6 | 2 | 0 | 1 | 191 |
| 20+Y, small city | 0 | 0 | 0 | 0 | 5 |
| 20+Y, town | 20 | 2 | 3 | 0 | 330 |
| 20+Y, countryside | 98 | 6 | 2 | 6 | 915 |
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, rural | 234 | 146 | 65 | 82 | 1531 |
| 6M-4Y, urban | 30 | 11 | 5 | 5 | 881 |
| 6M-4Y, semi-rural | 15 | 4 | 4 | 4 | 176 |
| 6M-4Y, large city | 7 | 3 | 1 | 3 | 386 |
| 6M-4Y, small city | 0 | 0 | 0 | 0 | 2 |
| 6M-4Y, town | 23 | 9 | 4 | 2 | 541 |
| 6M-4Y, countryside | 249 | 149 | 69 | 86 | 1659 |
| 5-19Y, rural | 283 | 78 | 9 | 28 | 645 |
| 5-19Y, urban | 42 | 12 | 4 | 7 | 404 |
| 5-19Y, semi-rural | 16 | 4 | 0 | 0 | 80 |
| 5-19Y, large city | 12 | 2 | 2 | 2 | 182 |
| 5-19Y, small city | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, town | 30 | 10 | 2 | 5 | 241 |
| 5-19Y, countryside | 299 | 82 | 9 | 28 | 705 |
| 20+Y, rural | 147 | 8 | 5 | 3 | 868 |
| 20+Y, urban | 23 | 3 | 0 | 1 | 430 |
| 20+Y, semi-rural | 1 | 2 | 0 | 0 | 104 |
| 20+Y, large city | 15 | 0 | 0 | 0 | 185 |
| 20+Y, small city | 0 | 0 | 0 | 0 | 1 |
| 20+Y, town | 8 | 3 | 0 | 1 | 273 |
| 20+Y, countryside | 148 | 10 | 5 | 3 | 943 |
The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: \>1 million habitants; Small city: \>50000 \& \< 1 million habitants; Town: \> 10000 and \< 50000 habitants; Countryside: \< 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, rural | 153 | 102 | 20 | 53 | 536 |
| 6M-4Y, urban | 15 | 1 | 0 | 1 | 312 |
| 6M-4Y, semi-rural | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, large city | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, small city | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, town | 15 | 1 | 0 | 1 | 311 |
| 6M-4Y, countryside | 153 | 102 | 20 | 53 | 537 |
| 5-19Y, rural | 184 | 49 | 14 | 11 | 186 |
| 5-19Y, urban | 14 | 2 | 2 | 2 | 142 |
| 5-19Y, semi-rural | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, large city | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, small city | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, town | 14 | 2 | 2 | 2 | 141 |
| 5-19Y, countryside | 184 | 49 | 14 | 11 | 187 |
| 20+Y, rural | 85 | 4 | — | 1 | 352 |
| 20+Y, urban | 2 | 0 | — | 0 | 156 |
| 20+Y, semi-rural | 0 | 0 | — | 0 | 0 |
| 20+Y, large city | 0 | 0 | — | 0 | 0 |
| 20+Y, small city | 0 | 0 | — | 0 | 0 |
| 20+Y, town | 2 | 0 | — | 0 | 155 |
| 20+Y, countryside | 85 | 4 | — | 1 | 353 |
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other and missing. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet, missing. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM walls - mud | 97 | 62 | 34 | 84 | 869 |
| 6M-4Y, MHCM walls - brick | 190 | 76 | 12 | 12 | 504 |
| 6M-4Y, MHCM walls - cement/plaster | 41 | 16 | 7 | 11 | 383 |
| 6M-4Y, MHCM walls - cement/paint | 29 | 12 | 5 | 11 | 408 |
| 6M-4Y, MHCM walls - other | 16 | 4 | 0 | 1 | 316 |
| 6M-4Y, MHCM floor - natural floor | 197 | 100 | 42 | 83 | 1079 |
| 6M-4Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 3 |
| 6M-4Y, MHCM floor - parquet polished wood | 0 | 0 | 0 | 0 | 2 |
| 6M-4Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 0 | 0 | 4 |
| 6M-4Y, MHCM floor - ceramic tiles | 0 | 1 | 0 | 0 | 30 |
| 6M-4Y, MHCM floor - cement | 170 | 69 | 16 | 33 | 1309 |
| 6M-4Y, MHCM floor - carpet | 6 | 0 | 0 | 3 | 53 |
| 5-19Y, MHCM walls - mud | 89 | 29 | 13 | 48 | 424 |
| 5-19Y, MHCM walls - brick | 119 | 23 | 3 | 4 | 223 |
| 5-19Y, MHCM walls - cement/plaster | 43 | 8 | 4 | 5 | 168 |
| 5-19Y, MHCM walls - cement/paint | 30 | 4 | 3 | 1 | 186 |
| 5-19Y, MHCM walls - other | 13 | 7 | 0 | 0 | 165 |
| 5-19Y, MHCM walls - missing | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM floor - natural floor | 146 | 46 | 12 | 48 | 511 |
| 5-19Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM floor - parquet polished wood | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 0 | 0 | 2 |
| 5-19Y, MHCM floor - ceramic tiles | 0 | 1 | 0 | 0 | 14 |
| 5-19Y, MHCM floor - cement | 146 | 24 | 11 | 10 | 607 |
| 5-19Y, MHCM floor - carpet | 2 | 0 | 0 | 0 | 30 |
| 5-19Y, MHCM floor - missing | 0 | 0 | 0 | 0 | 1 |
| 20+Y, MHCM walls - mud | 43 | 7 | — | 9 | 548 |
| 20+Y, MHCM walls - brick | 43 | 2 | — | 0 | 337 |
| 20+Y, MHCM walls - cement/plaster | 12 | 5 | — | 1 | 192 |
| 20+Y, MHCM walls - cement/paint | 16 | 3 | — | 0 | 217 |
| 20+Y, MHCM walls - other | 5 | 0 | — | 1 | 146 |
| 20+Y, MHCM walls - missing | 0 | 0 | — | 0 | 1 |
| 20+Y, MHCM floor - natural floor | 64 | 5 | — | 8 | 690 |
| 20+Y, MHCM floor - rudimentary floor | 0 | 0 | — | 0 | 2 |
| 20+Y, MHCM floor - parquet polished wood | 0 | 0 | — | 0 | 1 |
| 20+Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | — | 0 | 2 |
| 20+Y, MHCM floor - ceramic tiles | 0 | 0 | — | 0 | 13 |
| 20+Y, MHCM floor - cement | 55 | 11 | — | 3 | 705 |
| 20+Y, MHCM floor - carpet | 0 | 1 | — | 0 | 27 |
| 20+Y, MHCM floor - missing | 0 | 0 | — | 0 | 1 |
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM walls - mud | 49 | 30 | 15 | 29 | 1010 |
| 6M-4Y, MHCM walls - brick | 163 | 81 | 34 | 31 | 458 |
| 6M-4Y, MHCM walls - cement/plaster | 33 | 14 | 8 | 8 | 472 |
| 6M-4Y, MHCM walls - cement/paint | 32 | 15 | 4 | 2 | 393 |
| 6M-4Y, MHCM walls - other | 6 | 8 | 6 | 6 | 290 |
| 6M-4Y, MHCM floor - natural floor | 194 | 97 | 45 | 53 | 1145 |
| 6M-4Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 2 |
| 6M-4Y, MHCM floor - parquet polished wood | 0 | 0 | 1 | 0 | 6 |
| 6M-4Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 0 | 0 | 15 |
| 6M-4Y, MHCM floor - ceramic tiles | 0 | 1 | 0 | 1 | 40 |
| 6M-4Y, MHCM floor - cement | 84 | 50 | 20 | 22 | 1357 |
| 6M-4Y, MHCM floor - carpet | 5 | 0 | 1 | 0 | 58 |
| 5-19Y, MHCM walls - mud | 79 | 20 | 11 | 21 | 445 |
| 5-19Y, MHCM walls - brick | 155 | 26 | 11 | 7 | 191 |
| 5-19Y, MHCM walls - cement/plaster | 51 | 15 | 2 | 4 | 207 |
| 5-19Y, MHCM walls - cement/paint | 34 | 5 | 1 | 0 | 182 |
| 5-19Y, MHCM walls - other | 14 | 5 | 4 | 4 | 133 |
| 5-19Y, MHCM floor - natural floor | 207 | 42 | 17 | 26 | 508 |
| 5-19Y, MHCM floor - rudimentary floor | 1 | 0 | 0 | 0 | 0 |
| 5-19Y, MHCM floor - parquet polished wood | 0 | 0 | 1 | 0 | 5 |
| 5-19Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 0 | 0 | 10 |
| 5-19Y, MHCM floor - ceramic tiles | 0 | 0 | 0 | 0 | 26 |
| 5-19Y, MHCM floor - cement | 117 | 29 | 11 | 9 | 587 |
| 5-19Y, MHCM floor - carpet | 8 | 0 | 0 | 1 | 22 |
| 20+Y, MHCM walls - mud | 26 | 5 | 1 | 5 | 520 |
| 20+Y, MHCM walls - brick | 69 | 2 | 0 | 0 | 302 |
| 20+Y, MHCM walls - cement/plaster | 7 | 0 | 1 | 1 | 258 |
| 20+Y, MHCM walls - cement/paint | 15 | 0 | 0 | 0 | 215 |
| 20+Y, MHCM walls - other | 7 | 3 | 3 | 1 | 146 |
| 20+Y, MHCM floor - natural floor | 88 | 7 | 2 | 5 | 653 |
| 20+Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 1 |
| 20+Y, MHCM floor - parquet polished wood | 0 | 0 | 0 | 0 | 1 |
| 20+Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 1 | 0 | 4 |
| 20+Y, MHCM floor - ceramic tiles | 1 | 0 | 0 | 0 | 15 |
| 20+Y, MHCM floor - cement | 34 | 3 | 2 | 2 | 732 |
| 20+Y, MHCM floor - carpet | 1 | 0 | 0 | 0 | 35 |
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM walls - mud | 65 | 42 | 19 | 33 | 969 |
| 6M-4Y, MHCM walls - brick | 143 | 91 | 41 | 43 | 485 |
| 6M-4Y, MHCM walls - cement/plaster | 23 | 10 | 10 | 5 | 350 |
| 6M-4Y, MHCM walls - cement/paint | 28 | 12 | 3 | 5 | 464 |
| 6M-4Y, MHCM walls - other | 20 | 6 | 1 | 5 | 320 |
| 6M-4Y, MHCM floor - natural floor | 188 | 111 | 54 | 65 | 1082 |
| 6M-4Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 4 |
| 6M-4Y, MHCM floor - ceramic tiles | 1 | 0 | 0 | 0 | 26 |
| 6M-4Y, MHCM floor - cement | 85 | 49 | 20 | 25 | 1406 |
| 6M-4Y, MHCM floor - carpet | 5 | 1 | 0 | 1 | 70 |
| 5-19Y, MHCM walls - mud | 90 | 32 | 4 | 13 | 432 |
| 5-19Y, MHCM walls - brick | 161 | 42 | 2 | 12 | 205 |
| 5-19Y, MHCM walls - cement/plaster | 38 | 8 | 1 | 3 | 136 |
| 5-19Y, MHCM walls - cement/paint | 41 | 5 | 2 | 2 | 214 |
| 5-19Y, MHCM walls - other | 11 | 7 | 4 | 5 | 142 |
| 5-19Y, MHCM floor - natural floor | 185 | 67 | 7 | 24 | 449 |
| 5-19Y, MHCM floor - rudimentary floor | 0 | 1 | 0 | 0 | 0 |
| 5-19Y, MHCM floor - ceramic tiles | 2 | 0 | 0 | 0 | 12 |
| 5-19Y, MHCM floor - cement | 149 | 26 | 6 | 11 | 636 |
| 5-19Y, MHCM floor - carpet | 5 | 0 | 0 | 0 | 32 |
| 20+Y, MHCM walls - mud | 46 | 3 | 4 | 3 | 520 |
| 20+Y, MHCM walls - brick | 90 | 4 | 0 | 0 | 298 |
| 20+Y, MHCM walls - cement/plaster | 10 | 0 | 1 | 0 | 188 |
| 20+Y, MHCM walls - cement/paint | 15 | 1 | 0 | 0 | 228 |
| 20+Y, MHCM walls - other | 10 | 5 | 0 | 1 | 168 |
| 20+Y, MHCM floor - natural floor | 124 | 9 | 4 | 3 | 651 |
| 20+Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 2 |
| 20+Y, MHCM floor - ceramic tiles | 0 | 1 | 0 | 0 | 12 |
| 20+Y, MHCM floor - cement | 46 | 3 | 1 | 1 | 699 |
| 20+Y, MHCM floor - carpet | 1 | 0 | 0 | 0 | 38 |
The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM walls - mud | 33 | 14 | 2 | 14 | 127 |
| 6M-4Y, MHCM walls - brick | 92 | 76 | 17 | 33 | 231 |
| 6M-4Y, MHCM walls - cement/plaster | 23 | 8 | 1 | 2 | 120 |
| 6M-4Y, MHCM walls - cement/paint | 6 | 2 | 0 | 1 | 81 |
| 6M-4Y, MHCM walls - other | 14 | 3 | 0 | 4 | 289 |
| 6M-4Y, MHCM floor - natural floor | 97 | 76 | 15 | 37 | 267 |
| 6M-4Y, MHCM floor - rudimentary floor | 0 | 1 | 0 | 0 | 0 |
| 6M-4Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 0 | 0 | 2 |
| 6M-4Y, MHCM floor - ceramic tiles | 0 | 1 | 0 | 0 | 16 |
| 6M-4Y, MHCM floor - cement | 70 | 23 | 5 | 16 | 541 |
| 6M-4Y, MHCM floor - carpet | 1 | 2 | 0 | 1 | 22 |
| 5-19Y, MHCM walls - mud | 40 | 4 | 0 | 2 | 36 |
| 5-19Y, MHCM walls - brick | 114 | 27 | 9 | 5 | 78 |
| 5-19Y, MHCM walls - cement/plaster | 24 | 11 | 4 | 1 | 52 |
| 5-19Y, MHCM walls - cement/paint | 13 | 4 | 1 | 0 | 30 |
| 5-19Y, MHCM walls - other | 7 | 5 | 2 | 5 | 132 |
| 5-19Y, MHCM floor - natural floor | 105 | 27 | 9 | 6 | 96 |
| 5-19Y, MHCM floor - rudimentary floor | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM floor - ceramic tiles | 0 | 0 | 0 | 0 | 9 |
| 5-19Y, MHCM floor - cement | 89 | 24 | 7 | 7 | 214 |
| 5-19Y, MHCM floor - carpet | 4 | 0 | 0 | 0 | 8 |
| 20+Y, MHCM walls - mud | 18 | 0 | — | 1 | 76 |
| 20+Y, MHCM walls - brick | 52 | 1 | — | 0 | 171 |
| 20+Y, MHCM walls - cement/plaster | 13 | 2 | — | 0 | 70 |
| 20+Y, MHCM walls - cement/paint | 1 | 0 | — | 0 | 38 |
| 20+Y, MHCM walls - other | 3 | 1 | — | 0 | 153 |
| 20+Y, MHCM floor - natural floor | 50 | 1 | — | 0 | 201 |
| 20+Y, MHCM floor - rudimentary floor | 0 | 0 | — | 0 | 1 |
| 20+Y, MHCM floor - vinyl/asphalt strips | 0 | 0 | — | 0 | 1 |
| 20+Y, MHCM floor - ceramic tiles | 0 | 0 | — | 0 | 8 |
| 20+Y, MHCM floor - cement | 37 | 3 | — | 1 | 287 |
| 20+Y, MHCM floor - carpet | 0 | 0 | — | 0 | 10 |
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other, missing. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open, missing. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM roof - grass/palm | 112 | 53 | 22 | 44 | 453 |
| 6M-4Y, MHCM roof - iron sheet | 231 | 109 | 35 | 74 | 1980 |
| 6M-4Y, MHCM roof - tiles | 0 | 0 | 0 | 0 | 7 |
| 6M-4Y, MHCM roof - other | 30 | 8 | 1 | 1 | 40 |
| 6M-4Y, MHCM windows/eaves - closed | 193 | 93 | 31 | 77 | 1467 |
| 6M-4Y, MHCM windows/eaves - open | 76 | 33 | 17 | 20 | 486 |
| 6M-4Y, MHCM windows/eaves - partially open | 104 | 44 | 10 | 22 | 527 |
| 6M-4Y, MHCM windows/eaves - missing | 0 | 0 | 0 | 0 | 0 |
| 6M-4Y, MHCM, nets - not present | 322 | 157 | 54 | 91 | 1795 |
| 6M-4Y, MHCM, nets - present on all windows | 26 | 6 | 1 | 21 | 450 |
| 6M-4Y, MHCM, nets - present on some windows | 25 | 7 | 3 | 7 | 235 |
| 5-19Y, MHCM roof - grass/palm | 88 | 19 | 7 | 28 | 212 |
| 5-19Y, MHCM roof - iron sheet | 193 | 48 | 16 | 30 | 944 |
| 5-19Y, MHCM roof - tiles | 0 | 0 | 0 | 0 | 2 |
| 5-19Y, MHCM roof - other | 13 | 4 | 0 | 0 | 8 |
| 5-19Y, MHCM roof - missing | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM windows/eaves - closed | 154 | 44 | 14 | 38 | 669 |
| 5-19Y, MHCM windows/eaves - open | 71 | 16 | 5 | 9 | 233 |
| 5-19Y, MHCM windows/eaves - partially open | 69 | 11 | 4 | 11 | 264 |
| 5-19Y, MHCM windows/eaves - missing | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM, nets - not present | 256 | 63 | 21 | 42 | 853 |
| 5-19Y, MHCM, nets - present on all windows | 22 | 6 | 1 | 11 | 197 |
| 5-19Y, MHCM, nets - present on some windows | 16 | 2 | 1 | 5 | 116 |
| 5-19Y, MHCM, nets - missing | 0 | 0 | 0 | 0 | 1 |
| 20+Y, MHCM roof - grass/palm | 31 | 5 | — | 3 | 280 |
| 20+Y, MHCM roof - iron sheet | 84 | 12 | — | 8 | 1117 |
| 20+Y, MHCM roof - tiles | 0 | 0 | — | 0 | 6 |
| 20+Y, MHCM roof - other | 4 | 0 | — | 0 | 37 |
| 20+Y, MHCM roof - missing | 0 | 0 | — | 0 | 1 |
| 20+Y, MHCM windows/eaves - closed | 65 | 8 | — | 5 | 798 |
| 20+Y, MHCM windows/eaves - open | 25 | 5 | — | 2 | 291 |
| 20+Y, MHCM windows/eaves - partially open | 29 | 4 | — | 4 | 351 |
| 20+Y, MHCM windows/eaves - missing | 0 | 0 | — | 0 | 1 |
| 20+Y, MHCM, nets - not present | 107 | 12 | — | 7 | 1081 |
| 20+Y, MHCM, nets - present on all windows | 8 | 3 | — | 2 | 223 |
| 20+Y, MHCM, nets - present on some windows | 4 | 2 | — | 2 | 136 |
| 20+Y, MHCM, nets - missing | 0 | 0 | — | 0 | 1 |
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM roof - grass/palm | 52 | 32 | 16 | 23 | 509 |
| 6M-4Y, MHCM roof - iron sheet | 201 | 102 | 46 | 50 | 2092 |
| 6M-4Y, MHCM roof - tiles | 0 | 0 | 0 | 0 | 1 |
| 6M-4Y, MHCM roof - other | 30 | 14 | 5 | 3 | 21 |
| 6M-4Y, MHCM windows/eaves - closed | 97 | 54 | 30 | 39 | 1411 |
| 6M-4Y, MHCM windows/eaves - open | 88 | 45 | 20 | 19 | 669 |
| 6M-4Y, MHCM windows/eaves - partially open | 98 | 49 | 17 | 18 | 543 |
| 6M-4Y, MHCM, nets - not present | 242 | 136 | 62 | 66 | 1843 |
| 6M-4Y, MHCM, nets - present on all windows | 26 | 6 | 4 | 8 | 626 |
| 6M-4Y, MHCM, nets - present on some windows | 15 | 6 | 1 | 2 | 154 |
| 5-19Y, MHCM roof - grass/palm | 76 | 15 | 3 | 13 | 207 |
| 5-19Y, MHCM roof - iron sheet | 241 | 54 | 26 | 23 | 940 |
| 5-19Y, MHCM roof - tiles | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, MHCM roof - other | 16 | 2 | 0 | 0 | 11 |
| 5-19Y, MHCM windows/eaves - closed | 159 | 36 | 16 | 14 | 610 |
| 5-19Y, MHCM windows/eaves - open | 85 | 24 | 6 | 17 | 294 |
| 5-19Y, MHCM windows/eaves - partially open | 89 | 11 | 7 | 5 | 254 |
| 5-19Y, MHCM, nets - not present | 290 | 65 | 23 | 28 | 793 |
| 5-19Y, MHCM, nets - present on all windows | 36 | 5 | 3 | 6 | 296 |
| 5-19Y, MHCM, nets - present on some windows | 7 | 1 | 3 | 2 | 69 |
| 20+Y, MHCM roof - grass/palm | 30 | 3 | 1 | 2 | 276 |
| 20+Y, MHCM roof - iron sheet | 80 | 7 | 4 | 5 | 1144 |
| 20+Y, MHCM roof - tiles | 1 | 0 | 0 | 0 | 2 |
| 20+Y, MHCM roof - other | 13 | 0 | 0 | 0 | 19 |
| 20+Y, MHCM windows/eaves - closed | 49 | 6 | 3 | 4 | 732 |
| 20+Y, MHCM windows/eaves - open | 42 | 3 | 2 | 2 | 372 |
| 20+Y, MHCM windows/eaves - partially open | 33 | 1 | 0 | 1 | 337 |
| 20+Y, MHCM, nets - not present | 115 | 9 | 3 | 4 | 1033 |
| 20+Y, MHCM, nets - present on all windows | 5 | 0 | 2 | 3 | 320 |
| 20+Y, MHCM, nets - present on some windows | 4 | 1 | 0 | 0 | 88 |
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM roof - grass/palm | 55 | 35 | 12 | 26 | 464 |
| 6M-4Y, MHCM roof - iron sheet | 214 | 125 | 60 | 63 | 2111 |
| 6M-4Y, MHCM roof - tiles | 0 | 0 | 0 | 1 | 9 |
| 6M-4Y, MHCM roof - other | 10 | 1 | 2 | 1 | 4 |
| 6M-4Y, MHCM windows/eaves - closed | 164 | 82 | 38 | 57 | 1352 |
| 6M-4Y, MHCM windows/eaves - open | 86 | 67 | 28 | 30 | 845 |
| 6M-4Y, MHCM windows/eaves - partially open | 29 | 12 | 8 | 4 | 391 |
| 6M-4Y, MHCM, nets - not present | 244 | 149 | 63 | 84 | 1918 |
| 6M-4Y, MHCM, nets - present on all windows | 21 | 10 | 6 | 4 | 532 |
| 6M-4Y, MHCM, nets - present on some windows | 14 | 2 | 5 | 3 | 138 |
| 5-19Y, MHCM roof - grass/palm | 76 | 16 | 1 | 5 | 186 |
| 5-19Y, MHCM roof - iron sheet | 264 | 77 | 12 | 30 | 940 |
| 5-19Y, MHCM roof - tiles | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, MHCM roof - other | 1 | 1 | 0 | 0 | 2 |
| 5-19Y, MHCM windows/eaves - closed | 165 | 58 | 9 | 18 | 593 |
| 5-19Y, MHCM windows/eaves - open | 143 | 26 | 2 | 16 | 357 |
| 5-19Y, MHCM windows/eaves - partially open | 33 | 10 | 2 | 1 | 179 |
| 5-19Y, MHCM, nets - not present | 290 | 83 | 13 | 28 | 818 |
| 5-19Y, MHCM, nets - present on all windows | 31 | 9 | 0 | 4 | 261 |
| 5-19Y, MHCM, nets - present on some windows | 20 | 2 | 0 | 3 | 50 |
| 20+Y, MHCM roof - grass/palm | 45 | 1 | 2 | 2 | 259 |
| 20+Y, MHCM roof - iron sheet | 123 | 12 | 3 | 2 | 1123 |
| 20+Y, MHCM roof - tiles | 0 | 0 | 0 | 0 | 9 |
| 20+Y, MHCM roof - other | 3 | 0 | 0 | 0 | 11 |
| 20+Y, MHCM windows/eaves - closed | 112 | 9 | 4 | 1 | 715 |
| 20+Y, MHCM windows/eaves - open | 49 | 2 | 1 | 3 | 483 |
| 20+Y, MHCM windows/eaves - partially open | 10 | 2 | 0 | 0 | 204 |
| 20+Y, MHCM, nets - not present | 153 | 12 | 4 | 4 | 1052 |
| 20+Y, MHCM, nets - present on all windows | 11 | 0 | 0 | 0 | 262 |
| 20+Y, MHCM, nets - present on some windows | 7 | 1 | 1 | 0 | 88 |
The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, MHCM roof - grass/palm | 51 | 29 | 6 | 17 | 161 |
| 6M-4Y, MHCM roof - iron sheet | 111 | 67 | 14 | 28 | 673 |
| 6M-4Y, MHCM roof - other | 6 | 7 | 0 | 9 | 14 |
| 6M-4Y, MHCM windows/eaves - closed | 124 | 58 | 13 | 34 | 725 |
| 6M-4Y, MHCM windows/eaves - open | 15 | 13 | 1 | 5 | 66 |
| 6M-4Y, MHCM windows/eaves - partially open | 29 | 32 | 6 | 15 | 57 |
| 6M-4Y, MHCM, nets - not present | 156 | 95 | 16 | 51 | 712 |
| 6M-4Y, MHCM, nets - present on all windows | 8 | 1 | 2 | 2 | 79 |
| 6M-4Y, MHCM, nets - present on some windows | 4 | 7 | 2 | 1 | 57 |
| 5-19Y, MHCM roof - grass/palm | 55 | 10 | 1 | 2 | 51 |
| 5-19Y, MHCM roof - iron sheet | 134 | 37 | 13 | 9 | 276 |
| 5-19Y, MHCM roof - other | 9 | 4 | 2 | 2 | 1 |
| 5-19Y, MHCM windows/eaves - closed | 139 | 32 | 11 | 9 | 292 |
| 5-19Y, MHCM windows/eaves - open | 24 | 8 | 4 | 1 | 17 |
| 5-19Y, MHCM windows/eaves - partially open | 35 | 11 | 1 | 3 | 19 |
| 5-19Y, MHCM, nets - not present | 162 | 41 | 14 | 13 | 276 |
| 5-19Y, MHCM, nets - present on all windows | 17 | 5 | 2 | 0 | 25 |
| 5-19Y, MHCM, nets - present on some windows | 19 | 5 | 0 | 0 | 27 |
| 20+Y, MHCM roof - grass/palm | 27 | 0 | — | 1 | 98 |
| 20+Y, MHCM roof - iron sheet | 56 | 4 | — | 0 | 394 |
| 20+Y, MHCM roof - other | 4 | 0 | — | 1 | 16 |
| 20+Y, MHCM windows/eaves - closed | 64 | 4 | — | 1 | 421 |
| 20+Y, MHCM windows/eaves - open | 9 | 0 | — | 0 | 33 |
| 20+Y, MHCM windows/eaves - partially open | 14 | 0 | — | 0 | 54 |
| 20+Y, MHCM, nets - not present | 74 | 4 | — | 1 | 438 |
| 20+Y, MHCM, nets - present on all windows | 7 | 0 | — | 0 | 32 |
| 20+Y, MHCM, nets - present on some windows | 6 | 0 | — | 0 | 38 |
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water), missing; and Presence of electricity (PE): Yes, No, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 1) | Medium PD Group (Survey 1) | High PD Group (Survey 1) | Very High PD Group (Survey 1) | Neg PD Group (Survey 1) |
|---|---|---|---|---|---|
| 6M-4Y, MSDW - bottled water | 1 | 0 | 0 | 0 | 22 |
| 6M-4Y, MSDW - closed water source | 246 | 111 | 28 | 49 | 1637 |
| 6M-4Y, MSDW - open water source | 126 | 59 | 30 | 70 | 821 |
| 6M-4Y, PE - Yes | 66 | 24 | 7 | 13 | 780 |
| 6M-4Y, PE - No | 307 | 146 | 51 | 106 | 1700 |
| 5-19Y, MSDW - bottled water | 1 | 0 | 0 | 0 | 9 |
| 5-19Y, MSDW - closed water source | 182 | 41 | 13 | 19 | 767 |
| 5-19Y, MSDW - open water source | 111 | 30 | 10 | 39 | 390 |
| 5-19Y, MSDW - missing | 0 | 0 | 0 | 0 | 1 |
| 5-19Y, PE - Yes | 48 | 13 | 4 | 4 | 384 |
| 5-19Y, PE - No | 246 | 58 | 19 | 54 | 782 |
| 5-19Y, PE - missing | 0 | 0 | 0 | 0 | 1 |
| 20+Y, MSDW - bottled water | 1 | 0 | — | 0 | 12 |
| 20+Y, MSDW - closed water source | 82 | 10 | — | 4 | 943 |
| 20+Y, MSDW - open water source | 36 | 7 | — | 7 | 485 |
| 20+Y, MSDW - missing | 0 | 0 | — | 0 | 1 |
| 20+Y, PE - Yes | 18 | 5 | — | 1 | 397 |
| 20+Y, PE - No | 101 | 12 | — | 10 | 1043 |
| 20+Y, PE - missing | 0 | 0 | — | 0 | 1 |
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 2) | Medium PD Group (Survey 2) | High PD Group (Survey 2) | Very High PD Group (Survey 2) | Neg PD Group (Survey 2) |
|---|---|---|---|---|---|
| 6M-4Y, MSDW - bottled water | 1 | 0 | 0 | 0 | 4 |
| 6M-4Y, MSDW - closed water source | 207 | 93 | 44 | 42 | 1784 |
| 6M-4Y, MSDW - open water source | 75 | 55 | 23 | 34 | 835 |
| 6M-4Y, PE - Yes | 49 | 18 | 9 | 9 | 824 |
| 6M-4Y, PE - No | 234 | 130 | 58 | 67 | 1799 |
| 5-19Y, MSDW - bottled water | 1 | 0 | 0 | 0 | 3 |
| 5-19Y, MSDW - closed water source | 229 | 45 | 22 | 21 | 760 |
| 5-19Y, MSDW - open water source | 103 | 26 | 7 | 15 | 395 |
| 5-19Y, PE - Yes | 60 | 12 | 11 | 4 | 366 |
| 5-19Y, PE - No | 273 | 59 | 18 | 32 | 792 |
| 20+Y, MSDW - bottled water | 0 | 0 | 0 | 0 | 4 |
| 20+Y, MSDW - closed water source | 87 | 7 | 4 | 1 | 987 |
| 20+Y, MSDW - open water source | 37 | 3 | 1 | 6 | 450 |
| 20+Y, PE - Yes | 23 | 4 | 2 | 1 | 436 |
| 20+Y, PE - No | 101 | 6 | 3 | 6 | 1005 |
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 3) | Medium PD Group (Survey 3) | High PD Group (Survey 3) | Very High PD Group (Survey 3) | Neg PD Group (Survey 3) |
|---|---|---|---|---|---|
| 6M-4Y, MSDW - bottled water | 0 | 0 | 0 | 1 | 26 |
| 6M-4Y, MSDW - closed water source | 185 | 97 | 37 | 53 | 1613 |
| 6M-4Y, MSDW - open water source | 94 | 64 | 37 | 37 | 949 |
| 6M-4Y, PE - Yes | 36 | 25 | 8 | 11 | 775 |
| 6M-4Y, PE - No | 243 | 136 | 66 | 80 | 1813 |
| 5-19Y, MSDW - bottled water | 0 | 1 | 0 | 0 | 13 |
| 5-19Y, MSDW - closed water source | 214 | 51 | 6 | 23 | 715 |
| 5-19Y, MSDW - open water source | 127 | 42 | 7 | 12 | 401 |
| 5-19Y, PE - Yes | 56 | 19 | 5 | 7 | 348 |
| 5-19Y, PE - No | 285 | 75 | 8 | 28 | 781 |
| 20+Y, MSDW - bottled water | 0 | 0 | 0 | 0 | 15 |
| 20+Y, MSDW - closed water source | 101 | 8 | 2 | 1 | 884 |
| 20+Y, MSDW - open water source | 70 | 5 | 3 | 3 | 503 |
| 20+Y, PE - Yes | 19 | 3 | 0 | 1 | 386 |
| 20+Y, PE - No | 152 | 10 | 5 | 3 | 1016 |
The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg).
| Participants | Low PD Group (Survey 4) | Medium PD Group (Survey 4) | High PD Group (Survey 4) | Very High PD Group (Survey 4) | Neg PD Group (Survey 4) |
|---|---|---|---|---|---|
| 6M-4Y, MSDW - bottled water | 0 | 0 | 0 | 0 | 1 |
| 6M-4Y, MSDW - closed water source | 139 | 79 | 15 | 38 | 656 |
| 6M-4Y, MSDW - open water source | 29 | 24 | 5 | 16 | 191 |
| 6M-4Y, PE - Yes | 20 | 5 | 0 | 3 | 384 |
| 6M-4Y, PE - No | 148 | 98 | 20 | 51 | 464 |
| 5-19Y, MSDW - bottled water | 0 | 0 | 0 | 0 | 0 |
| 5-19Y, MSDW - closed water source | 155 | 38 | 12 | 9 | 247 |
| 5-19Y, MSDW - open water source | 43 | 13 | 4 | 4 | 81 |
| 5-19Y, PE - Yes | 23 | 8 | 3 | 4 | 161 |
| 5-19Y, PE - No | 175 | 43 | 13 | 9 | 167 |
| 20+Y, MSDW - bottled water | 0 | 0 | — | 0 | 1 |
| 20+Y, MSDW - closed water source | 69 | 2 | — | 1 | 391 |
| 20+Y, MSDW - open water source | 18 | 2 | — | 0 | 116 |
| 20+Y, PE - Yes | 9 | 2 | — | 0 | 206 |
| 20+Y, PE - No | 78 | 2 | — | 1 | 302 |
The malaria prevention measures (MPM) data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for each Survey. The MPM results include the following categories: Use of Mosquito coils over 7 days (UMc \> 7D), Use of Insecticide spray over 7 days (UIs \> 7D), Use of Commercial Repellents over 7 days (UCR \> 7D), Use of Traditional Repellents over 7 days (UTR \> 7D), Use of none of above over 7 days (Una \>7D), Use of indoor residual spray in past 12 months to spray interior walls (Uirs past 12M), Use of indoor residual spray - number of months ago (Uirs-nM) or Use of indoor residual spray- no spray (Uirs-no spray): the number of months ago for each Uirs-nM sub-categories is defined using the following \[x Months\]. Not all Uirs-nM sub-categories were analyzed in each survey.
| Participants | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) |
|---|---|---|---|---|
| [6M-4Y], UMc > 7D, Yes | 433 | 398 | 348 | 239 |
| [6M-4Y], UMc > 7D, Missing/No | 2767 | 2799 | 2845 | 954 |
| [6M-4Y], UIs > 7D, Yes | 101 | 60 | 48 | 27 |
| [6M-4Y], UIs > 7D, Missing/No | 3099 | 3137 | 3145 | 1166 |
| [6M-4Y], UCR > 7D, Yes | 4 | 5 | 24 | 20 |
| [6M-4Y], UCR > 7D, Missing/No | 3196 | 3192 | 3169 | 1173 |
| [6M-4Y], UTR > 7D, Yes | 7 | 9 | 0 | 2 |
| [6M-4Y], UTR > 7D, Missing/No | 3193 | 3188 | 3193 | 1191 |
| [6M-4Y], Una >7D, Yes | 2663 | 2726 | 2778 | 905 |
| [6M-4Y], Una >7D, Missing/No | 537 | 471 | 415 | 288 |
| [6M-4Y], Uirs past 12M, Yes | 59 | 15 | 7 | 3 |
| [6M-4Y], Uirs past 12M, Missing/No | 3141 | 3182 | 3186 | 1190 |
| [6M-4Y], Uirs-nM [1 Month] | 9 | 1 | 1 | 0 |
| [6M-4Y], Uirs-nM [11 Months] | — | — | 1 | — |
| [6M-4Y], Uirs-nM [12 Months] | 5 | 1 | 2 | — |
| [6M-4Y], Uirs-nM [10 Months] | — | — | — | 1 |
| [6M-4Y], Uirs-nM [2 Months] | 6 | 3 | — | 1 |
| [6M-4Y], Uirs-nM [3 Months] | 21 | 5 | 3 | 1 |
| [6M-4Y], Uirs-nM [4 Months] | 9 | 2 | 1 | — |
| [6M-4Y], Uirs-nM [5 Months] | 1 | 2 | — | — |
| [6M-4Y], Uirs-nM [6 Months] | 6 | — | — | — |
| [6M-4Y], Uirs-nM [7 Months] | 1 | 1 | — | — |
| [6M-4Y], Uirs-nM [9 Months] | 1 | — | — | — |
| [6M-4Y], Uirs-nM [no spray] | 3141 | 3182 | 3186 | 1190 |
| [5-19Y], UMc > 7D, Yes | 227 | 209 | 180 | 127 |
| [5-19Y], UMc > 7D, Missing/No | 1386 | 1418 | 1432 | 479 |
| [5-19Y], UIs > 7D, Yes | 45 | 32 | 20 | 10 |
| [5-19Y], UIs > 7D, Missing/No | 1568 | 1595 | 1592 | 596 |
| [5-19Y], UCR > 7D, Yes | 4 | 2 | 12 | 7 |
| [5-19Y], UCR > 7D, Missing/No | 1609 | 1625 | 1600 | 599 |
| [5-19Y], UTR > 7D, Yes | 3 | 3 | 0 | 2 |
| [5-19Y], UTR > 7D, Missing/No | 1610 | 1624 | 1612 | 604 |
| [5-19Y], Una >7D, Yes | 1336 | 1381 | 1401 | 460 |
| [5-19Y], Una >7D, Missing/No | 277 | 246 | 211 | 146 |
| [5-19Y], Uirs past 12M, Yes | 24 | 8 | 3 | 1 |
| [5-19Y], Uirs past 12M, Missing/No | 1589 | 1619 | 1609 | 605 |
| [5-19Y], Uirs-nM [1 Month] | 2 | 1 | — | 1 |
| [5-19Y], Uirs-nM [11 Months] | — | — | 1 | — |
| [5-19Y], Uirs-nM [12 Months] | 2 | 1 | 1 | — |
| [5-19Y], Uirs-nM [2 Months] | 1 | 2 | — | 0 |
| [5-19Y], Uirs-nM [3 Months] | 13 | 3 | 0 | 0 |
| [5-19Y], Uirs-nM [4 Months] | 2 | 0 | 1 | — |
| [5-19Y], Uirs-nM [5 Months] | 0 | 1 | — | — |
| [5-19Y], Uirs-nM [6 Months] | 4 | — | — | — |
| [5-19Y], Uirs-nM [7 Months] | 0 | 0 | — | — |
| [5-19Y], Uirs-nM [9 Months] | 0 | — | — | — |
| [5-19Y], Uirs-nM [no spray] | 1589 | 1619 | 1609 | 605 |
| [Y20+], UMc > 7D, Yes | 196 | 199 | 167 | 117 |
| [Y20+], UMc > 7D, Missing/No | 1392 | 1388 | 1428 | 483 |
| [Y20+], UIs > 7D, Yes | 46 | 30 | 28 | 11 |
| [Y20+], UIs > 7D, Missing/No | 1542 | 1557 | 1567 | 589 |
| [Y20+], UCR > 7D, Yes | 0 | 4 | 12 | 12 |
| [Y20+], UCR > 7D, Missing/No | 1588 | 1583 | 1583 | 588 |
| [Y20+], UTR > 7D, Yes | 4 | 4 | 0 | 0 |
| [Y20+], UTR > 7D, Missing/No | 1584 | 1583 | 1595 | 600 |
| [Y20+], Una >7D, Yes | 1346 | 1350 | 1392 | 460 |
| [Y20+], Una >7D, Missing/No | 242 | 237 | 203 | 140 |
| [Y20+], Uirs past 12M, Yes | 32 | 7 | 2 | 2 |
| [Y20+], Uirs past 12M, Missing/No | 1556 | 1580 | 1593 | 598 |
| [Y20+], Uirs-nM [1 Month] | 7 | 0 | — | 0 |
| [Y20+], Uirs-nM [11 Months] | — | — | 0 | — |
| [Y20+], Uirs-nM [12 Months] | 3 | 0 | 1 | — |
| [Y20+], Uirs-nM [10 Months] | — | — | — | 1 |
| [Y20+], Uirs-nM [2 Months] | 4 | 1 | — | 1 |
| [Y20+], Uirs-nM [3 Months] | 8 | 3 | 1 | 0 |
| [Y20+], Uirs-nM [4 Months] | 6 | 2 | 0 | — |
| [Y20+], Uirs-nM [5 Months] | 1 | 1 | — | — |
| [Y20+], Uirs-nM [6 Months] | 2 | — | — | — |
| [Y20+], Uirs-nM [7 Months] | 1 | 0 | — | — |
| [Y20+], Uirs-nM [9 Months] | 0 | — | — | — |
| [Y20+], Uirs-nM [no spray] | 1556 | 1580 | 1593 | 598 |
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
| Participants | Overall Study Group (6M-4Y) (Survey 1) | Overall Study Group (5-19Y) (Survey 1) | Overall Study Group (20Y+) (Survey 1) |
|---|---|---|---|
| P.Malariae, Pos | 19 | 21 | 1 |
| P.Malariae, Neg | 3181 | 1592 | 1587 |
| P.Vivax, Pos | 0 | 0 | 0 |
| P.Vivax, Neg | 3200 | 1613 | 1588 |
| P.Ovale, Pos | 3 | 1 | 0 |
| P.Ovale, Neg | 3197 | 1612 | 1588 |
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
| Participants | Overall Study Group (6M-4Y) (Survey 2) | Overall Study Group (5-19Y) (Survey 2) | Overall Study Group (20Y+) (Survey 2) |
|---|---|---|---|
| P.Malariae, Pos | 32 | 27 | 2 |
| P.Malariae, Neg | 3165 | 1600 | 1585 |
| P.Vivax, Pos | 0 | 0 | 0 |
| P.Vivax, Neg | 3197 | 1627 | 1587 |
| P.Ovale, Pos | 6 | 3 | 2 |
| P.Ovale, Neg | 3191 | 1624 | 1585 |
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
| Participants | Overall Study Group (6M-4Y) (Survey 3) | Overall Study Group (5-19Y) (Survey 3) | Overall Study Group (20Y+) (Survey 3) |
|---|---|---|---|
| P.Malariae, Pos | 48 | 27 | 0 |
| P.Malariae, Neg | 3145 | 1585 | 1595 |
| P.Vivax, Pos | 0 | 0 | 0 |
| P.Vivax, Neg | 3193 | 1612 | 1595 |
| P.Ovale, Pos | 6 | 4 | 1 |
| P.Ovale, Neg | 3187 | 1608 | 1594 |
Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results.
| Participants | Overall Study Group (6M-4Y) (Survey 4) | Overall Study Group (5-19Y) (Survey 4) | Overall Study Group (20Y+) (Survey 4) |
|---|---|---|---|
| P.Malariae, Pos | 32 | 28 | 0 |
| P.Malariae, Neg | 1161 | 578 | 600 |
| P.Vivax, Pos | 0 | 0 | 0 |
| P.Vivax, Neg | 1193 | 606 | 600 |
| P.Ovale, Pos | 3 | 3 | 1 |
| P.Ovale, Neg | 1190 | 603 | 599 |
Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity. Capillary blood sampling was the only invasive procedure involved in this study. SAEs related to this procedure were recorded at the Survey visit.
| Participants | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) |
|---|---|---|---|---|
| Number of Subjects With Serious Adverse Events (SAEs) Related to Study Procedure for Each Survey | 0 | 0 | 0 | 0 |
Collected over Capillary blood sampling was the only invasive procedure involved in this study. Serious adverse events (SAEs) related to this procedure were recorded at each survey visit.. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Overall Study Group (Survey 1) | 0/6,404 (0%) | 0/6,404 (0%) | — |
| Overall Study Group (Survey 2) | 0/6,414 (0%) | 0/6,414 (0%) | — |
| Overall Study Group (Survey 3) | 0/6,400 (0%) | 0/6,400 (0%) | — |
| Overall Study Group (Survey 4) | 0/2,400 (0%) | 0/2,400 (0%) | — |
| Age, Continuous(Years) | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) | Total |
|---|---|---|---|---|---|
| Mean | 12.6 ± 14.6 | 12.1 ± 14.3 | 12.1 ± 14.2 | 12.4 ± 14.4 | 12.28 ± 14.37 |
| Sex: Female, Male(Participants) | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) | Total |
|---|---|---|---|---|---|
| Female | 3670 | 3791 | 3752 | 1420 | 12633 |
| Male | 2734 | 2623 | 2648 | 980 | 8985 |
| Race and Ethnicity Not Collected(Participants) | Overall Study Group (Survey 1) | Overall Study Group (Survey 2) | Overall Study Group (Survey 3) | Overall Study Group (Survey 4) | Total |
|---|---|---|---|---|---|
| Count of participants | — | — | — | — | 0 |
Plan to share: Yes — IPD for this study will be made available via the Clinical Study Data Request site.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: IPD is available via the Clinical Study Data Request site (click on the link provided below)
Access criteria: Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.
Data sharing details ↗ · www.clinicalstudydatarequest.com
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.